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ABSTRACT 
The action of the hypoglycemic compounds, tolbutamide, 
chlorpropamide, me~ahexamide. at\d phenethylbiguanide, on the 
biosynthesis of cholesterol haa be .. investigated in vit" with 
-
mevalonate-2-C14 using a rat liver enzyme system containtng 
soluble enzymes pzaecipitated betweeD 30 ... 60% (NH4)2S04' microsomes, 
NADPH, NADH, and ATP tn 0.1 14 phosphate 'buffer, pH 7.4. The 
results show that the incorporation of mevalonate-2-c14 tnto 
cholesterol ia inhibited by all compouada .tudied. The mmd,mal 
inhibition occurs when the concentration of hypoglycemic compound 
is 4 x 10"" M. 
The marmer in which theae compouada inhibit cholesterol 
biosynthesis, however, is quite different. Phenethylbiguanide 
deereas.. the formation of the non-aaponifiable lipids and 
choi.,sterol by approximately the same amount from m.evalonate-2-
C14• This would ~ly that phenethylbiguanide inhibits the 
biosynthesis of cholesterol before the formation of the choles-
terol intermediate found :in the tlOll. ... sapotlUiable lipid fraction. 
This 1s substantiated by the inhibition of squalene formation 
from mevalonate-2_C14• Furthermore, there is an accumulation of 
the isoprenola. pre-squalene cholesterol iatermediatea. Reverse 
phase cbromatogra~ of the 3,S-dinitrobenzoate derivatives of 
the alcohols showed that the accumulation of radioactivity was in 
the famesol derivative. It follows that phenethylbigwmide 
interrupts the biosynthesis of cholesterol at the. level of the 
C1S-isoprenel, fa~601 pyrophosphate. 
'1'he. aryl.aulfanylureas, tolbutamf.de, chlorpropamide, and 
metahexami4e. however, are different as regards their effect O'l\ 
the biosyatheaia of cholesterol. !hey do not inhibit the incor-
poration of mevalonste-2-C14 ~to ~e non-saponifiable lipid and 
cholesterol by the same magaihde. Startfng with mevalonate-2-
C14, there is almost no difference between the non-saponifiable 
lipid formed wb_ the aryl sulfonylurea eempounds are pre.ent or 
absent froB the tncubation mixture, aDd yet cholesterol biosyn-
thesis 1s inhibited. When the isoprenels and squalene are iso-
lated, th..-. again is no difference. Whea, however, lanosterol 
was isolated, tibere was a decrease ta its formation corresponding 
to t1\e de ...... 4tbtained in cholesterol ayathesized from 
mevalonate-2-Cl4• And finally, wheat squalene was iaolated after 
aerobic ineubatlcrna. there was an i:rtcreaa. in its formation when 
tolbutatd.de was preaent in the f.ncubatiGn adxtul"es. The increase 
in squale1\e fOl'lDaUon from rae.valonate-2-c14 could be explained by 
the decrea.. in the bioayntbes1a of cIao1eaterol in the same In-
cubations. It foll...,8, therefore, that tolbutamide inhibits 
cholesterol biosynthesis from mevalonate-2-Cl4 between squalene 
and lanosterol. or more precisely, at the cyclization of squalene. 
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CHAPl'D. I 
TIl! IIOS'DTHISI8 or CHOLESTIllOL 
In 1942. Blocb .DeI Rttt"'", (22) cliscovered that when 
isotop1c.lly l.beled .cetic .cid i •• ~iD1atered to an ant.al. or 
is .deled to the incub.tiOD Mdi .. of tissue prepar.tions. i.otopi 
c.lly l.beled chol .. terol CaD .ubsequently be extracted fra. tbe 
oraana of the ant.al or from tbe ti.aue prep.rations. It i. now 
pos.ible to outline .o.t of the reactions of .terol bio.ynth .. i. 
fro. acetate. The known .equence in tbe for.ation of Chole.terol 
frOll .cetate 1a ....... r1&ed 111 riaur. 1. It can b. divided into 
tbr .. phases: 1) .eet.t. - .... l ... t •• 2) .... lonat. - squalen •• 
and 3) squalene - cholesterol. 
ACETATE - MlVALORATE 
Th. first two .teps in chol.sterol biosyntbesis involve 
.ctiv.tion of acet.te to acetyl-Col and condens.tion of the latte 
to acetoacetyl-Col.. '!'b .. e st.,s are .. 11 .stablisbed reactions 
and involve other .. tabolic pathways besid.s cholesterol bio-
synth .. is. th.y involve th. for.ation of ac.tyl adenylat. fro. 
acetate and ATP whicb then r .. cts with coea.,.. A to for. 
.c.tyl-CoA and AMP. loth .tep. of th. reactioa are catalysed by 
2 
TABLE 1 
INTERMEDIATES Df CHOLESTEROL BIOSYNTHESIS 











Squalene Lanosterol ----+- CHOLESTEROL 
3 
a siDa1e .. ,.... acetic tblo1d.nase. 'ftte nat stq_. a COIld_-
satin of acetoac.ty1-eGA with acety1-coA, baa been studied 
ext.stv.1y 'lty beID.y (126) and L)'D- (94). 'l'b ••• ,.. r.spon-
sible for the r .. ction, HJ«I-CoA-cond.s1D& .. ,.., ha. been 
partially purified fro. ,. .. st (53). The process liberate. one 
_leeule of eoeDa7IM A, wbieh c ... from the acetyl and DOt froll 
the acetoacetyl aroup, producina 3-bydroxy-3-.ethy1 a1utary1-CoA 
(HHC-CoA). A1Choup the reaction i. not ... 11y rever.ible, HMG-
CoA can " irreversibly cleaved 'by another .. ,.... HMC-CoA 
cleavq ... ,.., to ac.toacetate _d Acetyl-CoA (126). This in 
effect produc.. a hydrolYSiS of acetoacetyl-eGA and is tboulht to 
produce fr .. acetoacetate in the liver (6). 
The coover.loo of HMG-CoA to mevalonic acid by a solub1, 
... ,.. .yst. bas bea extensively studied by Dun, Rudn.,., aDd 
'_pson (47) (52) (127) ad by Lyaen (91) (9.5). It is apparentl, 
caealysed by • sinale ana,..., HMC-CoA reductase. POI' ..,ery _1. 
of HNG-Col raduclMl. ODe IIOle of MVa10nate is fonaed. two _1 .. 
of MDPR are o.d.dlaed, and OIle _le of coena,... A i. r.l ...... 
'l'be ..,.. ccmtaias au 1 fhydry 1 &roups .. s.tial for the catalytic 
activity.. evldenced 'by the face that the reduction tak.. place 
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which baa been pres ___ d to be • part of chole.terol hiosynthesi. 
" •• ,rov.a 'y Durr &ad R.ucla4ay (46) not to h. involved. th. f.ct 
that th. fr.. aldehyde, 1I8Va1die acid t is DOt aD 1DterJledi.te in 
the react10a does not preclude the possibility that ..valdle 
acid is aD 1Dt ...... iat. 1D tbe blosynth .. 1a of cholest.rol. 
the possibility that ena,..-bouad ..va1die acld or its 
thiGh_iaeetal are iDterMdiat .. still r_1Ds. The over-all 
reaction, therefore. prohaly proceeds 1D a two-st., __ ar with 
aD eas,..-bound .... ldat. or its tbiah..tacetal belDi _ int.r-
-.diet. in the reduction. It is appareGt1y catalyzed b, • slnal. 
_,.a. aDd auob reaction. apparectly proceed throuab .. ,.... 
bound iDter.edlat .. (111) (133) (139). 
Ttl. strikina feature of thl. reductlon la that it 1. 
irreversible. HMC-CoA redu.ctaa.. whatever the acturc.. is 
atereoapecific for the natural optical enantio.orpb (t) of 
JIG (85). "'s far •• it is Imown. ODce ... alOGic acid ia foraed 
FIGURE 2 
THE BIOSYNTHESIS OF CHOLESTEROL 
FORNATION OF MEVALONIC ACID 
<;U3 













eoeu.,.. A 1. no lemael" required for furtber reactiODs. The 
a...... of th... reactlou 18 ...... In rlaur.. 1 and 2. 
MEVALOHATE .. SQUALID 
The aecond phaa. of the bio.yaCh .. ta of choleacerol 
lDvo1v.. .evera1 ... ,..tic react10fta which convert ..va1onic acid 
to aqua1ene. 
The transforation of lIIIVa10Dic acid to uopenteny1 
pyropboaphate i. effected by thr .. ATP-dependent at.pa, catalysed 
respectiv.ly by mevalonic kina •• (142) (91) (87), ..valonic 
pbo.phokiDaa. (18) (71) (21), and a decarboxyla.e (18) (21) (145) 
(3) • 
Mev.1ODic acid. by th. actioa of ...,a100ic kiD •• e and 
ATP, ~. pho.phorylated to yield pbo.phom8valonic acid (141) (125) 
(144) • 'lbe ... ,.. cat.lysin. thi. reaction .... to be aD 
SR-en.,.. aiace it ia inhibited by p-chloro.ercurib .... te. 
Mevaloa1c kin.ae, •• ther fro. ,ea.t or liver, i. .tareo.pecific 
for the natural enantia.orpb (4) of ..valODate juat a. RMC-COA 
reduct .. e vas atereo.peclfic for (f) HMC-CoA.. 
When 5 .. pbo.pbo-(2-C14)~.lonate I, incubated without 
ATP, there i. no production of .tero1. Thi. aUlleated that a 
further pboapbory1ation tak.. place. The eaa,.. c_taly.ina thia 
8 
reaction haa been parti.lly purified fro. pll liver by Popjak (69) 
and catal,... the reversible foraation of '-dlpboaphomevalon.te 
trca phosptt-.v.10llate _d Aft (r1pre 3). The polition of the 
equilibria. 11 .. 011 the slde of the forward reactiOll aDd pes .t 
optt.u. r.te in tbe prea_ce of MI++ lOlls. Aa tbe phospho-
..... 10l11c kiDaae react1cm is rever.lble, lt i. evld_t that the 
s.ODd pho.phate bond 1ft 5-dlpbo_pbo •• valoute 1_ an _erl1 rich 
boDCl. prol».l, of the ._ order of _ituel. .. that of ATP. 
!b. decarboxyl.s. .yet. i_ _1'. oOllpl_ aad i. 
characteriaed by _everal uau.ual ieatur... 'lbla __ ,-, which 
hal ..... partially purified 1»,. Bloch ... .&1. t (21) cat.l,... • 
reactlon betweea 5-dipbo • .....,.loaat. and ATP to for. 110-
penteD,1 pyropho.pbatet CO2, ADP, aacl P04. It h •• been IUlle.ted 
that the decarboxylation proceed. via. labile phoaphate e.ter, 
5-dipbo.pho-3-pbo • .....,.lon.t., .ine. p32 contained 11'1 ATp32 
uled 1D the reaction did DOt appear 1a the ilopeoteD,l pyro-
phosphat. (32) (93). Recefttl, L1acIberl. Y\IaD, deWaard. and 
Bloch (88) have obtaiaec:l avid_c. th.t definitely poiatl to .. 
iDter.ctlon bet .... the ter.1n.l phosphat. of ATP and the tatiar, 
alcobol &rOUP of 5-dipbo.ptt-.valonlc .cld and IUlleat that this 
interactlon !acilitat.. c-o cl •• v.... Th. intermediary for.ation 
PIG"uRE 3 
THE BIOSYNTHESIS OF' CHO~TEROL 
PHOSPHORYLATION OF HEr-vALONIC ACID 
?I2OH 
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of a covalent pbo.pbate •• ter, '-pboapbo-'-dipbospboaevalonle 
acid, which could •• a... tIM favorable 81x ... riered rin& structure 
(Plpre 4, .cb_ .) 1. a poa.1bi11ty, 'but in the absence of 
direct evidence alternative fOrallationa earmot 'be ruled out. 
The type of traDafer of 018 fro. tub.trate to P04 .t 
daaonetrated by Bloch .1£ .&1. J (88) baa been observed :In a number 
of A'fP dependent .ynth .... (25) (84) (67) (140). yet in ftO case 
h .. the .. cb.an1etieally probable phoaphoric eater int ...... 1at. 
bea lMlated. Buchanan.lt.l1., (28) have au .... ted a eoaeerted 
mechard.M for nucleophilic d1aplac __ t reactionl :lnvolYina thr .. 
subltrat.. aDd thr .. reaction producta. The prOpMed .. chaDi .. 
18 applicable to the varioua .ynth .... that are coupl .. to the 
el.." .. e of ATP to ADP ad P04 eel can he exteaded to the 
decarboxyla.e react1. (Flaure 4. sell_ b). with the lIOCIificatioa 
that ODe of the d1.plae __ tl 18 hltra- 1natead of latenaolecular. 
Bloch (18). bowver. poillt. out that th1a .till do •• DOt rule out 
the iDt .... tary foraatiOD of 3-pbolpbo-S-dipbolpbome'lalonlc acid. 
The poallbll1Cy that the carboxyl p"oup ratber than the tertiary 
hydroxyl &rOUP of 5·dipbo.~aloaate 1. attaeked by the 
tand.Dal pbolpbate of AD baa b.. fOUDCl to be ialpro1tabla. 
11 
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Althousb the formation of 180peatenyl pyrophoaphate 
and ita incorporatlon into th. aqualene 1I01acule baa been proven 
to take place (93). the lDa'DDer 1D which thla tak .. place 18 'till 
a aubjec:t of wide r .. earch. S1nce at the two ends of the 
aqual .. _1 .. 1e the aroup:1na (CBS> 2C-CH- appear.. it follow 
that an 1aGIariaat1oD of the iaopeteayl pyrophosphate to a 
cU..thylallyl Ib:ucture ... t occur at 80188 at_. With the 
partial purification of the __ ,.. iaopentea.yl pyrophoaphate la...... (93). 'tIblch COl1Verta laopenten,l pyrophoaphat. to 
d1Mthyla1ly1 pyrophoaphate. the bypath.ala of the 1a __ 1&at1oa 
of laopeat_,l pyrophosphate vaa experiMatal1y proven. Thia 
reaction could be .viaioned as beiDa 1Ditiatecl by • protOll 
followd ):', 8ft .IS.1aaeloo of a HCODd proton fr_ the mo1ecul. 
aa allow 1D Flaure .s. 
'lhe a)'Debui' of aqual.e proceeda fro. a a .. le. of 
co04 .. aaciou iDvolvlDl .lectropbllic addition to doubly Nuad 
-thy 1.. poupa. Dillethylallyl ,yrophoapbate. in ea GO with 
other .... t_e .. 1D wbich • pot_tially ao1oa:l.o sroup (in chi, 
c... .aterU1ed vith • pyropboapbate) II :I.D the alpha poalt.ion 
to • double boad. are .lectrophll1c. Loa,.f the pyrophosphate 
fro. eueA su.atee .... ,. "cur readily. for tile reault1Da .lec-
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tron-deficient .peel.a 1. ,artlally atab111aad by r.aooence 
bet ... two equlvalent foral 
, '+ e-G.c 
• t 
t t + (C-C-c) 
• t 
~ t _-..~ c+. c· c 
, . 
+ OR-
Aa vaa at.~'" Miore, tha all_ type .ub.t_c.. ara .t ... , 
elactrophl1!c ca.pounda ... could attack a ter.taal .-thyleae 
aroup. 'fbl •• lectropllillc: ..... u. could occur .1ther vla the 
tnt~.di.t. 100 or .. • b~lec:ular d1.'l.c .... t. 
'Dua .. t probabl. flr.t cODd .. at1oll l .. d1q to the 
fonaatioD of aqua1 .. ,. MCWHD d~yl.llyl pyroplloapbat •• nd 
laopentan,l pyropbo .... t. (92). with the .lilli_tion of pyro-
pboapbate ioD In. the diaathylallyl pynpboaphata (I'lpre 5) ." 
carrl.. .. .. c .. a of poalt1ve char.a INt at_Illation ., occur 
by a1 i eSaatloD of • proton 11v1Da riae to .-reDy1 ,yr~pbate 
(92) • III ..... 71 pyrophoaphat. we have ... 1D ... lactropblilc 
r .... t. which call coact.aaa w1c1a .. tbar _lec\ll. of Uopeat.,l 
pyropbo.pb.at. 10 the a ____ .a th. coracl •• at1ora of the latter 
1.S 
with dtmethylallyl pyrophosphate. Again by stabilization through 
eltatnat10n of a proton, the product, farn.ayl pyrophosphate (92), 
is obtained (F!aure 6). 
It ia not kno1«l whether the two condensations are 
cataly.ed by two different eoz,..., 'but the formation of seranyl 
and fames,l pyrophosphate. 18 readily d.aonatrated in a liver 
enzyme system. Lynen.t.t..Il. t (93) syntheslzed d1methylallyl and 
garanyl pyrophosphate. and obtained the formation of iaranyl and 
farn .. ,l pyrophoaphatea with an enzyme system prepared from y .. at 
and frOID soluble supernatants of liver homosenatas. 
Farne.yl pyrophosphate, a CIS isoprenoid substanc., 
re8ambl.s squalene tn the fact that a tail to tail condensation 
of two molecules would &ive ris. to .qualene. Although it 1s 
still not pos.ible to define preci.ely the reaction sequence in 
the biosynthesis of squalene from farn •• yl pyrophosphate, the 
poaaible typea of aechanim have been narrowed down. In any 
proposed -.chant.. the following exper~tal facts have to be 
accounted for: 1) the 10 •• of ana H atom from C-l of one 
farn.syl pyrophosphate DOlecule. 2) the replacement of this H 
atom with the hydride 10n from NADPH; 3) failure of incorporat1oD 
of a proton froe vat .. into squalene durinl biosyntheais frOlB 
16 
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2. Hypothetical isomerization of tamesyl pyrophosphate to 
nerolidyl pyrophoaphate: 
~3 
R-C-C-CR2 , , 
o H 0-, / 
P 





iaruM),1 pyropbo.pbat. (119). an4 4) the probable partlcipatloD 
1'1:'_ th ... r.lu1ta PopJak .IS. .I! .• (119) 4_uc_ th. 
fo1low1D, .--al featur .. of a .. 1 ..... loa,.thaale. It 1. clear 
that aD eel "rica1 ps'OC'" .at ... 1avo1vad 1D th. 1.at at .. of 
1 .. 1- ... lolyath .. le. OD. of the tw cODden_in, lam .. ,1 
pyropboapbat. _l_ule. ...t ... _Jact to r .. etiou dUferent 
fX'. tboa. of th. other. !he ro1. of MDPS in the b!08",th.ale 
CaI'laot be the reduction of • double bond. for 1D that eveat th. 
uptake of • protOD fro. th. lae __ t1oa .... 1.. .. w11 .1 tbe 
tr.lf.r of th. hydrid. :loa &a. IlADPH should have Mcu.ned. 
TIt. proe .. 1 .. y lavo1.. the 1 ...... 1 .. t1on of one 
farn .. yl pyropbOlpb.at. _lHU1. to nerol1d,l pyrop!loapbate aa 
h ....... IUII.lted by Cornforth and Popjak (41) (40) and Popjak 
(116). Such an laomerl •• t1oa il DOet readl1y envll .. ed ...... lnl 
dle r ... 1t of aD lac .... 1 pbo.pIlac. rean .. _t (r1pr. 6). 
a1tboqb leparatlem aDd reattac __ t of pyropboapbat. 100 COl'l-
Ititut •• other poelib11it,. By. proe .. 1 _lopua with the 
blo.,.Cheata of .... ,1 aDd fara .. ,l ,:rropbolplaate froa 
diaetb.y1allyl _d iaopent.eay1 pyropboepbate t.be two hblt_cea 
could oODden •• '-y a 1NC1eophl11c proe.... It il IUppoaeci that 
the condensation is assisted by the phosphate anion in nerolidol 
pyrophosphate and that the cyclic ester (I. shown in Figure 7) ia 
the first intermediate, althouJh the fo~t1on of intermediate 
(II) need not necessarily involve that of the cyclic ester. 
Reduction of this intermediate by NADPH with an allylie rearraDze-
mant may give squalene directly. 
An alternative mechanism also postulated by Popjak at 
JJ.!., (18.5) involves a reaction with methionine which 't«)uld give, 
with or without an allylic rearrangement, the sulfonium compounds 
(III) and (IV) shown in Figure 8. The former (III) could be 
reduced with NADPfl in the same way as (II), except that no proton 
participates. The reduction of (IV) t not proceeding by way of an 
allylic system might be akin to the reduction of a car.bonyl group 
by NADPU. 
The above mechanisms cover all the known experimental 
observation. on squalene biosynthesis from farnesyl pyrophosphate. 
The evidence of the enzymatic formation of nerolidol in liver 
enzyme systems, however, is not entirely convincing (63) (116). 
The conclusion that the reaction 1s a genuine formation of the 
nerolidol derivative rests on the appearance of free nero1idol 
after hydrolysis of a mixture of polyprenol derivatives with 
R== 
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snake v8DOa pbosphat... and also froa th. reductioD of a fr .... -
dried alkaline apeeiMn of th ••• d.rivative. with LUIS. in .ther 
(117). Occurrence 10 plant oila of an optically activ. Derolidol 
alao s",porta the idea of tb. ena,..tic iaameriaation of a 
darivative of fam ... l to that of the t.rttuy alcohol nerolidol 
(119). The iao.erlaatl00 probably proceeda .a a ruult of 
1Dtemal pboapbate rearrana __ t ('lp.re 6). altboqb a .. ratiOll 
aIld reattacb.1leat of pyropboapbate loa constitut.. another poa-
sibillty. 
Tbe dlscussion ao far aaaUMel that the e1fainat1on of 
Ofte H at_ .. a protOll, orl&1na1ly att.acb.ecl t.o e-l of fam .. ,1 
pyropboaphate (or to e-s of ..valODate), occurred froa tbat unit 
of farueayl pyrophoaphate _ieh waa .ul»jeet to the 1 .... 1aatiOD 
to nerol1cly1 pyrophoaphate. HCMJVer. thi. need not aee .. aarl1y 
be .0. A •• umins qa1n the l_riaatlon of farneayl pyropbo.pbate 
.. before, the rearr&DI~t of lDterMdiate (V) to a aubatance 
coata1Dina the cyclopropane riDl (VI) i. alao a posaibility. 1ft 
thia caa. the .li.jaation of the hydroaea at.. occurs fro. the 
.ide opposite to that conaidered in the previoua .ech .. i .... 
Squal_e could tb.a\ aria. fr. the reductive 01..".,. of the 
yclopropan. riq tdth I1AJ)PH aDd the ccmcert_ elWaat1.oa of 
the pyropbosphate anion. 
SQUALENE .. CHOLISTDOL 
there are three plac.. in the ebol •• terol molecule 
where a repeatina pattern of live carbon atoaaa appears, containin 
acetate .. thyl and carboxyl atome in an i.opentane structure. 
This fact was first recognised by Bloch (15'> after dearadation 
of the aide chain of chol •• terol biosynthesised from C14.1abeled 
aeetatea, and prompted him to revive the old hypotbesu that 
.qualene, a d1hydrotriterpene, is an intermediate in ebolesterol 
blosynth .. :s.a (16). The firet experiaent.l proof that .qualen. 
••• • part of chol •• terol biogen.ei. ... obtained by Lanadon and 
Bloch (86) wbo .howed that .tIU8len8 •• s a1Dthee1sad by rat liver 
frOta ac.t.t.. 'lb. conver.ion of .... 1 .. lato aterol baa aiDe. 
b •• confined by Mauad.l. Tcben, amd llocb (99) 1Iho obta1Dad the 
conv.raion of .qualen_ into lanosterol. 
Th. oyeli •• tion of acaual.. to lanoaterol 1s cat.lys.d 
by the .. .,.. .qu.l •• oxidocycl.... 'lb. 1nitiatilll .peel .. 
actina on .qualen. is ... aaed to be a o.tiODle oXYI_ .t_ ••• 1. 
oat. Th. • • ..,tion c.... fro. th. f.et that __ aev.loole .cid 
1. incubated with r.t liver ru-oa-.t .. und.r an ae..ph..-e of 
nltrol_ only ..... 1... 1. aynth.a1&ecI. When oXYlen la substituted 
2J 
~or 111croa_. cbQl .. cerol 18 .'-oat t1ae 081, product that CaD be 
i.olated With very little _flUelen_ Min, pr ... t (118). 
The cyc11.atioa of squalene proc .... without tbe 
forutloo of _table 1Dt-=-ciia1:U (20) by a CODeereed electro-
phil1.: ... 1t1_, ac...-1eci by rearr ___ t and tera1 .... ted by 
expula10n of • pro"", (49). A feacure of ebb mecheni_ 1_ a 
8l1t1p1. 1: 2 _1ft to electrcm-def1c:.ieat CeDter.. 'the two 
auplaJ: ..cbyl aroupa betweea r1D&. C and .u of lanoaterol bave 
botb, it 1a poeCUl.ted, reacheel their final poa:.itioaa by .iaratioa 
fraaa -1abboriDI carbon _COIla. 1'h1 ... lIDa Chat aro"p B of 
..... 1 .. (a .. below) Decoae attached to C-ll of l .. aterol aDd 




This hypotbeaia was exper~cally proven in a 
brilliant .et of experiments by Cornforth ~!l., (38) (39) (42a) 
and Mauadal, Tchen, and Bloch (99). FrOal the data, the process 
waa po.tulated as being a forward eycliaation initiated by the 
oxygenated cation lead ins to an electron deficiency at C-20 
followed by a cooc.rted backward rearranaement. One hydrogen 
mov .. to C-20, and another to C-l7; a _thyl &roup move. to C-l3, 
and another uthyl aroup to C-l.. The hydroa. at position 9 1a 
fwlly expelled to fon the double bcm4 in laDostarol. In otber 
worda, the teer.cyclic syst. is foraed before the rearrana-..t. 
A detailed -..eh8Diam of this eyeliaaCion i. abown in !'iaura 9. 
The cODVeraion of lanoaterol to chol .. terol require. 
the r..",al of three _thyl &roup., reduction of the D. 24 -double 
bond, and a "shift" of the nuclear double bond frOll position ~ 8 
to poSition ~ '. The .. chan ism by which the.e chaaa. occur and 
the .equence in which they occur are poorly understood at this 
tiM. The controversy centers around the 6 24 double bond. The 
ar, ... t 1s whether or DOt the recluct10n of this double bond 
occurs early or late 1n the 8 ... ence. At the __ nt, Doth 
possibiliti.. appear to be true. 
Iloeb .t!. .tl.. (61) (77) have aaOlm that 4,4-diMthyl-
HO 
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choleata-8.24-dien-3- iJ-Ol and .,.oaterol (cbol .. ta-8.24-dieaol) 
can he biologically cOIlverted to choleatwol. SteiDbua and 
AviaaD (136) (5) have 1deotlfl_ d ... aterol (chol •• t.-S.24-
d18OO1) 1D rat. and .an after treatment with MER-a" • hypo-
cboleaterol.aic aubatance. and .hown ita tranafor.atlOft to 
eho1eaterol !9. litg. o.e of the pathwaya. tb.refore. would 
cOlltaill acluatve1, compouada viCh a 24,25 double boad 1a tbe 
alde ch.ta (Table 2). the firat of th ... reactioaa ia the 
oxidative r_v.1 of thr .... thyl lroupa fre. lano.terol (62). 
The ruction .... to proceed via the carboxylic analop.. which 
are thea cUtcarboxylatecl to yielel thr .... lecu1_ of CO2• The 
,roe .. a r84U1r .. _leeular oxya- ad IfADPR. 
The _thy1 p'oup attached to C-14 of lao.tarol 1a 
.It.t~ted firat, yie1dtna 4,4-dt.8thylcbol .. ta-8,24-dlea-3- ~.Ol 
(62). '11le replac __ t of hydroa_ ,roc..- without cbaDp in 
coafipratioa. The two .. thyl pou,. at the 4 poaitioQ are 
el~tn.ted Dext with the prior fo~tion of '-keto derivativ ... 
Bloch .. Al. t (62) (19) baYe po1Dtecl out that a keto p-oup at 
e-3 woulel facilitate the clecarboxylatioD of ( a -keto) acida 
foruel by oxidation of the .ethyl &rOUpa OIl C-4. 
It i8 not yet k.- _ich of th .. e tw p-oupa 18 
27 
elf.1l.1nated first. After the removal of the second methyl ,"up, 
the keto group at C-l i. apparently reduced again yielding 
zymosterol (chol.sta-8,24,dienol). Zymaseerol could then underao 
twO double bond ".hifts" from D 9,10 to D 5,6 produeing 
de8lllOsterol which upon reduction of the D 24,H double bond 
would prGduee chol .. terol. 
On the other hand, .. 1dance has a1.0 been aee~lat1n, 
that a lUBber of aterola with a .. aturated atde chain may have a 
role in choleaterol biosJ1lth. .. ia. I1U'.!£.Il., (14) bave shown 
that D 7 -cbol .. ten.ol 1. rapidly coavert4Ml to ebol.sterol. 
N.ld.mls .. and Wall. (110) have identifled 4- a -aechyl- D 7. 
abol .. taol 1D rat tt ..... and d .... 8erated it. corrveratoa to 
cb.oluterol by isotopic _thods. 811111.- conversion of _tho-
sterol iD a .yst. !!!. nCrl baa been reported by hanta .!! .Il .• 
(60). ItarKlatch .. Ilua •• l (79) have 1801ated 24,2.5-dtbydro-
lano.terol, 4- a __ tbyl-D 8.cbol .. tenol, 6 7.chole.tenol, and 
7-deb.ydrochol .. terol frma a lIOUIJe t ... r aDd obeerved labelilll of 
the.a aterols DY Cl4 acetate. 
The aeeODd pathway froa lanoaterol eo ehole'terol, tb_. 
lavolv.. the reduction of th. 24.25 double boDd of leosterol .. 
the fuat atep produc1a& dibydroI8llO.terol. _ich then would loe. 
28 
the three methyl groups by the mechanism described previously, 
followed by a "shift" of the 8,9 double bond to yield 6 1. 
chole.tenol, which upon another "shiftU of the double bond to 
position S.6 would eventually produce Cholesterol. 
A recent report indlcat.s that the latter a.chant.. ia 
probably the major one occurrins in phY'iological syat .... 
Schroepfer (129) has found that sterols with 6 24 double bond 
are not 81plflcant intermediates in the conversion of lano-
aterol to chole.terol. Z,...t81.'lOl (~ 1 ... choleateool) ... found 
to be more r .. dily convertible to cholesterol than ... zymo.terol. 
Th. cbrOlUtogr_ of the sterola obtained ft'OlB the boIIo.enata 
incubated with .,.,atenol waa aua .. tive of the pr •• ence of thr .. 
radioactive c08lpC)UlUla IIOre polar cbroaatographlcally than 
cholesterol. One of the.e compound. va. t8Eltatively ideatified 
•• 7-dehydrocholesterol (cbol_ta-'. 7-41_-3- (3 -01) on the b .. i. 
of the cftrcaatosrapbic behavior. 
laDdutch (78) bas found that rat liver homogenatea 
readily convert 7-dehydrocholesterol into cholesterol with NADPH 
•• a cofactor. It would .... therefor.. that the final "shift" 
of the D 7 ·bond involv.. the formation of • 6::. S bond first 
followed by a reduction of the ~ 7 bond to produce chol •• terol. 
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s 4-B-Methyl-A -eholestenol 
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1 
A 7 -Cholestenol 
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7-DehydroCholesterol 









The fiDal tl"aasfOl'llatiou of 1 __ tarol to ebol .. terol ara 
.unBlr!'" in Table 2. 
Cbol .. t .. l i.. therefore, _t1rel,. 8yatbeaiaed fre. 
acetate. ly .... t ...... 8 to be _ in'ever.1bl. reductioD of 
IIMG-CoA. ill aotive *I'Ii11briu. with acetate, ..,aloDie ac1d Is 
fomed _ida 1a tb_ COIlYerted iDto 18opeat-.,.1 pyropbo.pIlat. 
bavirla 'both aucl_pb11ic ... e1eeaopb1110 activity. Utili.illa 
bocb of th ... actlv1tl .. they live ri •• to beeN.dtat_ 
<pr.,.l ad fara .. ,,1 pyrophoapbatu) It, a had to tail 
pol,...1uC1on. larue"l pyrophosphate tb_ 1. .... Jolaed 
tail to tail to prod.ac ..... 1... Scpaa1 .. e retda. 11UOleopb.ilie 
activit", 07cl1.181 1:0 l.o81:e1."01, wid .• .".tuall,.. .,,. a .. r1.s 
of reacti __ , produc .. chol .. tero1. 
CHA.lTD. II 
TIll IIOCHDlISftYOr HYJIOOLYCIHlC COMPOUJU)S 
HISTORY 
Dlabet .. .a11itua , ....... lo .. ~11o 41aorc1e1' 
charact.r ..... "7 • di.t_baH 01 lipid ... cU'Mb,cb:ate ..cabo-
11_ ad .. Uut_ b, .......... toler ... to c ....... yclr.t •• 
!he oonclltloa • .,.lops either __ the pre4uctloft of iIlauliD is 
1DacIeqaat .... __ tile dCl_ .f laaulla .. the ti ..... u 
anta.-tud. 
MaDy f_t, led to the Nlul tbat CIae pa1ICI'''' pro-
duced a boraeae _lch .... ec ... .,. for dte ... 1 _talteliaa 
of oa:noh,cIr.... I. I •• ', VOD Merta ... 111_ .. i (102) ..... 
that the r_09a1 of the ,"'1'''' caHd d1al:tete. _111cua. It 
, •• ad likel, that til. duetl ... lalees of ~ .... the 
source .f •• eerecion, ......... c __ the ',..G •• '. 
De He,. (lOS) iD 1909 ,_.ted the __ "",&It for eM 
hypetlletiw iDt .... 1 leeretloa of the .. erqa. 
It ... DOt atl1 1922 thae "tina aM ... t (7) (I) (9) 
succeed .. ill atractiRI a pr .... at1oD I ......... 1 .,........ coa-
t.1II1.. tile _tUiabetle ur_ iD • fon 1IIlicll coa .... tatly 
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alleviated all manif •• tations of diabetes in totally depan-
cre.thed do,s. 
Ever 8inee the isolation of taeu1to, a •• arch for or.l 
hypoalyeemtc compounds ha. been 1n effect. In 1926, Frank, 
Nothaan. and Waper (57) reported the hypOllyc_ic effect of a 
d1guanide, synthalin. Grah. and Linder (65) etudied this 
coa&potJ.nd and found that it caused severe liver d_,e. and it 
waS soon abandoned as a hypoglycemic compound. 
Plant extract. have been us.d for a lonl tilDe as 
reMdi •• for diabetes mellitus in many parte of the world. For 
ex_pie, Allen (2) investigated blueberry leaf extracts and 
Hush-Jon .. (73) studied the extracts of perlw1Dkle, mistletoe, 
and nlckerberry. Many other plants po.s.s marked hypoglyc_lc 
properties. The two alkaloid.. ,alepine (108), from the seeds of 
GAIH' 2fflcina11a, aDd lapartine, from the seed. of L!Pipu! albus. 
have the property of reduclns blood eUler of nonul individual. 
and diabetics. Other materials with hypoglycemic properties have 
been extracted from a wide variety of plant tis.ue. and bacteria 
(37) (89). 
Ha.sall. Reyle, and Feng (68) teol.ted • hypoglycemic 
compound froID the unripe ".ckee... the fruit of a plant t 11iM!. 
• '!hie c "ieh 
called Hypoa1ycin A. Anderson.!S..i!., (4) and Ell1ngton, Haasall, 
and P11uaer (48) detm.-mined that the hypoglye_ic activity .. a 
due to an amino acid, whose structure 18 given in Table 4. A 
second hypo,lycem1c compound has alao been isolated from the ... 
plant and the name Hypoglycin B was given to it (68). It is a 
polypeptide composed of HypoglyciD A and alutamic acid. 
A DeW era of hypoilycem1c oral compounda b.aan 1n 1942 
when JaD1itoD, Chaptal, Vadel, and Schaap (75) discovered tbat 
S-l.opropyl-2-sulfanilamide-l,3,4-thiad1azole (a180 called IPTD) 
poa .... ed hypoalyc.ue properties. Fillally, Franke, Achelu, 
Betra .IS. .fl., (1) (13) (58) found that l-butyl-3 ... aulfooylurea 
(alao called by its seneric name carbutamide) had a hypoilycem1c 
capab~11ty. Since then. many hundreds of cb_1cally related 
compounds have been atudied for their hypo,lycaaic activity 
(30) (98). 
the majority of theae C08IpOUDda and preparatlona vere 
found to be too tOld.c for luJID8D use, but three analo,_ of 
carbutamide. namely tolbutmaide, chlorpropa:J.4e, and metah __ jde 
have .,.. subjected to clinical .tud:l. •• , and two of th., 
tolbutamide and chlorpro,.14e, are be18& ext.alvely uaed for 
the treatMnt of 11114, adult, diabet.. M1lieua. 'l'he third, 
..calla_We, ... v1tbclr __ fre. the .. rue bee .. e ie did DOt 
off_ ., iJIportant n.w litenefic1al futur ... 
DlSOLD AJU) THE AltYLSULJ'ORYLUltIAS 
a. replac-.t of the ,...iAo JI'OUP of carbut_ide 
wldel, uaecl :1a diaMte. therap,. tollMataa1de (R-butyl-II'-p-
tolu_lfOD,lurea, .... tiaoft. OriIIae, D 860. or U 2043). 1'he 
chaD .. of tile ... tltated arouP _ the MDa.e rSaa 11 re.poa-
.:1bl. for __ , lIIport_t "101oateal differ_ce •• 
III __ • tolbute1c1e t. converted lI'1to freely 801ubl •• 
DOG-toxic. carboxylic acid (II-bat"l-.' -p-carboxypb_,laulf0ll1l-
urea) b" oxlclaticm of the , __ thyl ••• citu_e (90). .-but,l-II'-
p-h,..."..,llulfOl1,lur .. baa ala. .... fOUDd iD blood I.a very 
_11 ..... t.. riaally, Mobn1ke _d Wltt .... _ (105) i801ated 
fr_ the ur1u of cI.p a toxic ..c&bol1te of tolbutam.e. 
p-eolu_lfODaide and .ocher cOIIpOUl'ld 1Ihic:h .... ... later 
to be ,-tolueDMUlfoo11urea (106). 'lbe el1aiDation of tolbuta-
aid. 1a doH by the kieJae,. •• _101, a. the carboxylic acid (55). 
TolbucaRide a. ccmtraeted with carbut-'cIe. doea Mt .1p1f:l-
cantl, affect thyroid funetlO1l .. .. .... eeI b, 1131 .twlt ... 
(101) • The .l ...... t of the lO:lter procluciDa propert:l .. of 
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the arylaulf_ylur... coaea from th. removal of the ,-_lao 
group (97). 
Ollorprop.-1cl. (If-propyl-N' -,.cblorobeueDe au.lf0l.\11-
urea, O1aben •••• P 607) cllff ... fr_ tolbutam.de 1ft the fact that 
the ,....cbyl &rOUP of tol1Mac.lcle i. replaced b1 a chl.iDe at_ 
aDd the alkyl radical, but_. la replaced by propane. 1D_. 
thi. eo.pouad, lD COIltr .. t with tol'*t ..... la probably DOt 
aataollud before .. er.tloD. .. clef:Lnlte cbr_toaraphlc or 
ultraviolet _aorptioft diff_.c .. hav • ..,.. fouad beh'MD the 
pur. cb:u& aacI tbat b • .,. OJ." viDe (76) (138). V.iq tbe uriDe 
of clop treated with cblorprop_icle-S3S• however, thr .. diff_at 
c~top:apblc .pot. were ct_actad. !hey .... lel_tlfled .. th. 
UDCbapd eo.pouad, p-dllorob __ ulfoaylurea. _ p-cbloro-
and 20 per c_t reapective1y. 'l'bJNld fuDctiOll a ....... ad hy 
,1_ prot.lD-houDd iocIiDe level. and tbe thyro1cl upCak. of 
radioactiv. iodiD. 1. DOt iJlpUreci by chlorprop .. de (135). 
~ab .... lct. (.-oyoleb..,l-.· ... ('.I8da0-4-toluea.aulfo-
Dyl)urea. ,,17Cb) 1. a VflrI effective bYPOl1yeeeic eo.pouad 
with a duration of action whlch 18 lonpr thaD tbat of 









and about five times as effective as tolbutamide in producing 
sustained blood levels (82). Dogs and rabbits excrete 30 to 35 
per cent of the administered metabuamide dose unchanged in the 
urine and 40 to 50 per cent as 3-amino-4-benzenesulfonamide 
(l25a). Since it was found the metabaxaaide caused obstructive 
jaundice (56) (96), the compound has been withdrawn from 
clinical studies. 
Insulin is a polypeptide which, when taken orally, is 
rapidly destroyed by enzymatic action in the gaatro-int.stinal 
tract. Althouab attempts have been made to protect the insulin 
from being diguted, preparations livinS adequate absorption when 
administered by aouth hcve been unsucces.ful. Daily injections 
are needed for patients with diabetes mellitua in order to 
maintain load health. Since it haa been found that the action 
of insulin is influenced by the size of the crystals (151), 
different preparatioDs have been made utilizinl zinc suspensions, 
protamine suspensions, amorphous zinc insulin, and different 
combinations of the above. By usin& different ratios of these 
preparations, altaost any desired duration and potency can be 
attained. 
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~x;rRAPANCREA'rIC EFFECTS Of TH~ ,H.l{YWULFON~LUR£AS 
The mechanism by ~ich tolbutamide and other hypo-
g11c-.10 aryl.ulfonyluraaa exert their hypoalycaaic actio~ 1& 
atlll riiapu.tad. It 111 PDerally aaread that in ..... la the 
aryl.ulfOllylurua produce bypoglycaaia only when a01Be funct10niDa 
pancreatic bate-celle are pre. ant • Houa •• y ami Penhoa ( 7 2) at., -_ 
that the pr .. ence of ... pancreatic ti •• ue 18 ... ential for the 
bypoalyc.u.c effect of the aryl.ulfonylur.... The arylau.lfayl-
ureaa reduca the iaatina blood au,aar level of intact and 
partially pancreatectomized or mildly alloxan diabetic anima18, 
but they do not do 80 after total pancreatectomy 111 daP. rabbit •• 
rata, or un (104) (149). nor 111 miaal8 IUd •• everely diabetic 
with allOUD. 
AltbQU&h the avid_c. indicat .. that their adm1niatra-
tion reault. 10 deer ..... iDaultn tn tha pancr .. tic vein (113) 
(120). __ ,. .. tabol!c effecta which accoaapaDY arylaulfonylure. 
1nchtcecl hypoalyc..u are eo differant fro. thoa. which accOIIPatl, 
iDaulin :lDduced hYPGllyc.u.a that a .. iaveatiaatore poatulata 
tbe preaenc. of .. jor eatr.p&Dcreatic factora of ary18u.lfoDylurea 
act1oa. 
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rat liver sllc •• , have been found to decrease epinephrine-induced 
glycogenolysis (l43c) and ketogenesis (24). When rat liver 
homoaenates vere used J tolbut..tde was fOUl'ld to alter the 
activity of a number of enz,..., including at least one 
trans..maa. (23), aeveral NAD aad MADP requiring ayst ... (147) J 
and the phosphoryl .. e reaetlvat:iua ayet. (11). 
To1butaa1de and chlorpropamide administered Ja ylvo 
deer ... " ketos_ •• ia (24) (27) (SO) (124). To1butamde ad111nls-
tered !a nyo, with the .ffeet _.surad 81ther in vivo or !n 
~itro. has Mat found <a> to decr.... .1uco.. output (l28a). 
(1:») t.o 1Dereaa. the 8yneh.sla of 11ye_, facty ac1cla, aad 
protaia, without the eorr .. poad1aa atrabepatic .ffects .een 
with 1uullD (123). (e) to deer .... th. coavars1ota of fructos. 
8IlCI plactoae to a1 .... (122). .. (eI) to altar the activity of 
~ _,...a, 1acluc:liDI iDcn:eaaed activity of .. lie .. ,.. 
(146) (147). 
Cblorprep..tda .. y, UDder eart.ira coadltiou, sliebely 
1ncr .... tbe 11yeo .. coat_t of rat diapbrap, _11. UDder 
.t.11ar coaditl00e tolbut..td. baa DO aff.cts (35). Cblorpro-
,..1de al&. aodaratel, .apr..... 81ut..to-oxalac.tlc tr ... ..ta ... 
aetivicy ia tba liver. of wl1 fad atdu1& (128). 
THE GUANIDINE DERIVATIVES 
In 1926, Frank, Hothman. and Wagner (57) ayntheslHC1 
Synthalln A (decamethenediguanlde) after earlier reports .tated 
that the administration of guanidine lowers the blood sugar 
concentration (148). A f_ diabetic patients were treated with 
SynChal1n A, but it was subsequently proven to be quite toxic 
ev_ ill ... 11 dos .. (12), produein& hi.tololical chan ... 10 the 
liver and kldney and all cl1oi.cal ua8 of the ccapound was 
diacoat1Dued • 
In 1957. the bypoglyc.u.c effect of phenethylb1guanida 
(N'-beta-pbenethylformamid1oyltainourea hydrochlorlde, DII, 
fbeafonain, Dibotin) w.. described by Schapiro, Parrino and 
Freedman (130). They ioYa.tipted approx1aately two hundred 
aono- aDd di- substituted alkyl and aromatic derivatives of 
foaaadiny11la1nouraas, and found the pheaethylbipalde w .. a 
hi8bly active oral bypollyce.ic eo.pouad in both Dor.al end 
alloxan-diab8tic animal •• 
Th. Mda of actiott of ph.ethylh1panide 18 different 
ira. that of tha arylaulfonylurea. a. the compound produce. 
hypo&lyc.na in pancreatectOlBiaed animals (109), in severa 





GUANIDDlE AND 0'J.'HE1l HYPOGl.ycmac COMPOUNDS 
H~ ... ~ ... NH2 Guanidine 
mt 
H_N ... 0 ... NH (aH2 ) NIl ... 0 ... NR2 Synthalin A (u=10) T' n n. tt Su'ftthalin. 8 (n=12) Nil Nil ., .. 
O H ~ ... (CR2 )",N'R - C ... NH - C ... N Pbenethylbtgwmide ~ # "n "t NH NH It 
at2c,'" /0 .. CR2CHC02 - Hypoglycin A 
" Ha 
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insulin-deficient type of diabetes (114). Ph enethylb iguanide 
increases the glucose uptake by the rat diaphrap !!l vitro, whi1. 
the musele Ilycog80 content decre.ses (152). A marked increase 
in lactic acid production and a decrease in oxygen consumption 
su..ggeat that phenethylbiguallide stilllulatea anaerobic glycolysis 
by inhibiting oxidative enzyme .yst .... 
Wick, Larson, aDd Serif (1.50), uSing adipose tissue, 
have .bawD that phenethy1b1guanide inhibits the oxidation of 
,lucoae, acetate and .uccinate and coD8lclerably reduces fat 
synth .. 18. In man, the blood pyruvate and lactate levels are 
raised ('1) and there 1. DO chana. 1n hepatic vein gluco.e, urea, 
pyruvate or lactate, DOt: in the oxygen conaUIIPtlon of the liver 
(143.) • Lactate lavale 10 the blood from the £..ora1 artery 
also r_in UIldlanpci. Hypo"lye_a cannot b. produced in normal 
humans by the adatnistratioa of pbeaetbylbiguanide (51), althoulb 
with iatact _illa1a • deer .... in the blood sugar concentratlon 
la ... 11y produced. Thea. reaults auaaest that the effeets of 
pheaetbyU,ipanide are lar,al, mediated in the peripheral 
ti.sues. 
Tha tissue anoxia sugeated by this avid_c •• , be 
attributed to inhibition of cytochrome oxida.e and succluic 
F 
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dehydrogenase (137) (143b). but a decrease in oxidative phos-
phorylation would have the same result. Later work suggests 
that biguanldes inhibit the transfer of enerlY rich phosphate 
bonda to adenosine diphosphate (50) (31) (121). 
Phenethy1biauanide haa also been found to s ignifi-
cant1y increase the levels of s.ru. inoraanic phosphate (132) 
1IIb .... the arylaulfony1ureaa decrease the serum inorsanic 
phosphate (74) (138). Williams ~~., (152) found that 
phenethylbiauaDWe inhibited phosphoryl... phosphat.s.. the 
ana,.. catalys1na the conversion of phosphorylase a to pbos-
pbot:y1 ... b. They al.o fOUDd that the compound had no effect 
on the activity of phosphoryl... a or phosphoryla.. b or on tb. 
enzyme depbosphophospboryl ... kinde which catalyzes the con-
version of phosphoryl.s. b to pho.phoryl .. e a. An inhibition 
of phosphoryla.. phosphat ... in vitro would favor an incr .... 
in the amouat of pboaphoryl.s. a pruent in the ti •• ue. Since 
phosphoryla.e a 18 believed to be the form of the .. ,. active 
in ,lycOlerlolysi., tbu could account for part of the d.er .... 
in Ilyco .. produced by pheutbylblauanic:le. 
RYPOCLtCBNlC COMJIOUllDS AID STDOL MBTAIOLUH 
Altbou.ah .tud1 .. _ th •• ffec' of ca. hYPOllyca.1c 
til. lac tea y..... 01117 r __ cl, baY. .y report. a"..racl 01\ 
tbe .ffect .f th ... c ........ OIl crhol .. terol MtaboU.. 
SId.pp -.4 MUaroe (131). clurtaa the ,..t year, ..... 
fouad that t.l ...... t_1 .. aultatalltial1y deena.eeI blood .ol .. t.rol 
1Il bypereholMtero1e.1c ... hyparalyceaic patieDt.. Ira 
tile blood CODc_traCioIl of cIaoleacerol ... al_ aoucl (29) (13) 
(66). o.a (112) .. .,.hd tbe .ffecc. of tollMa' ..... _1erpro-
,.. ... ad ac.coha_lda OD tIM blood .. l .. tRol, COtal 11,1c:1a, 
aacl fr .. fatt, ac14.. !be ata iIld1eaUl tbat all tIar .. 
&1')'18,,11_,1 ..... that .... ".eeI 1B the tav .. tiaatiaa lowered 
tbe chol .. t ... l 1 ... 1. of tbe patiat.. riDa11,. Lrbert (8S) 
hal reported tIlat pheutbyl1d.paa14. reclucecl tU total ... 1 .. -
cero1 l .... la of the blood ill 15 ouc of 30 d~le ,.eiat •• 
Til. 'uppz' ... i_ of daol .. terol bio.yDtla .. 1a by tile 
b".a1ye..t.c •• , ouacl. 1I1aht partial 1, ..,laiD til. 10wftiq of 
bloocl .. l.. cu.1 ob ... eeI after the ada1a1..trat1_ of eb. 
b".,1, ... 0 cOllPOUJlCl.. Una.l1 .. .I1., (11) aot .... 1acr __ 
p 
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incorporation oJ: mevalonate-C14 iDto cholesterol in poorly 
controlled diabetes and ketoacidosis, while Hennes and ReddLQa 
(70) reported tbat the incorporation of acetate-l-C14 into 
~~olesterol in diabetics is decreased after administration of 
chlorpropamide. 
Reduced lipogenesiG and incr ... ed lipolysis are 
recoaniaed features of tne diabetic state. the increased fat 
mobilization resulting from a deficient insulin effect OD adipo.e 
tissue can account for the increased blood concentration of free 
fatty acids. 'l'be mechanism for the incr.... of cholesterol in 
the diabetic 18 less clear. Siperstein (134) ltas suggested. that 
excessive quantities of acetate and acetoacetate derived from 
lipolysis are diverted toto ketone bodi.s and cholesterol 
synthesis. 
Altnougb acetate and acetoacetate mi&bt be diverted 
into ketone and cholesterol synthesis 10 diabetes mellitus, they 
are not incorporated into sterol durina treatment with the 
hypoglycemic compounds (10). la vitro studies have sbown that 
tolbutamide, chlorpropaadde" metabexamide, and phenethylbipanide 
inhibit cholesterol blosyntheaia from acetate-l-c14 (44) (45) 
(100) (101). Consequently. it would b. of great interest to 
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Know at what step in the biosynthetic pathway of cholesterol 
biosyntheais the inhibition takes place. '£be dissertation will. 
therefore, deal w.lth otudies in the elucidatiOD of the sita of 
inhibition of eOOlaatuol biosynthesis by the hYP'Oalye.uc 
compound., toliNt.u.da. c::b.lorpropamide ... tahexamide. aDci 
pheaethylb1guanide. 
CHAP'rD. 111 
MATD.IALS ABD METHODS 
'ftle .. terial. aacl .. hod. u.ed in the inveatiaatiem of 
the aite of 1nb1hition of chole.terol hioayntheais by h"ollyc..tc 
co.poanda are described in this chapter. 
MATERIALS 
Aft&l!l. - The ent.ala •• lected for ua. in the exper1-
I18Dt. were Sprape-llavley .. Ie rat. obtained fro. Abr.. s.all 
Stock Breeder.. Chicaso. Illinois. t'he rata. ".ipina approxi-
mat.l, 200 11' ... , were kept on a replar diet. Sacrificinl"s 
done by decapitatiem. 
Bxpg&lxc!!!ic CO!!pO\!ndl - Tolbutamide, aodi_ salt 
(lot ICJO II, '84-2) and _tah __ id. (lot #CJo 12. 860) was 
aupplied by The Upjobn CoIIpaa,. Kal.a.oo. MichilaD. Phenethyl-
b1luanide hydrochloride (lot 121) .al supplied by U. S. Vit..tn 
Corporation. a.., York, ... York. Chlorpropamide (lot 103-422-
021PD) vaa supplied by Charle, Pfiau ad CcapanY. Inc., ... 
York. Ifew York. 1'be purity of th.,e hypoalyc_ic c.,ouacl, 
corre'poDd, to that of analytical &rade rea.ae,. 
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gsg,... • 1l1cotm.1dta _.10. dtDueleotlde. reduced, 
dl.041w1 s.lt, (lW>B, chr..aCOp'apbically pun, lot: 16501), 
alcoch,_ld. __ iDe d!auol_tl ... phoaphat., reduced, Mdl_ .alt, 
(1W)PH, cbr_COp'apblcall, pur., 10c 16103) aad ad.iDe td-
phoapbate. d1aodt. .alt. (Aft, lot 113'-A) .... ot.taiDed fre. 
, ..... t LaI:toratori... Mil...... Wiacouia. Glut.tbioM, reduced, 
(GSR, lot 164'24") ... ObC.iDed fro. Califoni. Corpor.tloD for 
I~.l ........ Lo. ",.1 .. t Cal1forala. 
MI!J1oBl! .c&._1_CI4 ... ""II011c .eld·a.C~ • OL· 
Mev.loaie acid 1actODe-l-C14 (lot '1) ... _ta1aecl fro. lhaclear-
Olio.., CHpor.t1oll. DH 'lalrau, I111rlola. Tbe 8rtp.al .,.if 
activity of 3. " fII:/fIM .. dlluted vitia _label_ DL-Mvaloaic 
acid l_COM (lot 112634) _ta1Md fro. MaaD a ...... eIl Labor.torie 
IDe., .. York. II. York, to • _,.tfic activity .f 0.16 .:/ •• 
Th. purity .f the labeled .... laDO-1aCtoae was ell .... 'y the 
_faaeurer " dilutSa aaal,._ta ... ,.,.. chroIIatop'apll, .. 
fouacl to ... 9.-992. ,.. •• 
DL-~a1oa1c acid-Z-C14 .. the ••• ·d~71-.tb11_. 
dl ODi ..... s.a·('.' dibJ*0x7·3-Mtbyl .. t .... t.) •• It (DIID 
•• It) ... oIJt.tDed &. _. Baal_d )Jucl .. r Cocper.tioa. _toR, 
..... achuett.. 11l. orliSul specific act.ivit" 1.19 .c/rM., •• 
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diluted to a particular level (shown in the tables of re.ults 
under "Conditions") with unlabeled DIED salt of mevalonic acid 
(lot ID3l05) obtained from Mann Research Laboratori... The 
specified purity by the manufacturer was 99.St as evidenced by 
the radioautogr .. of the DBED .alt of DL-.... lonic acid-2-C14 
given in 'isure 10. 
In earlier experiment., DL-mevalonic acid 1actone-2-Cl4 
(lot 115) obtained from Nuclear-Ch.icago Corporation, was uaed. 
The .pecification. and dilutions were the .... &8 liven for 
DL-mevalonic acid lacton.-l-C14• 
Other chemical. - The sourc.s of other chemicals used 
in the inve.tigation are stven in rabl. 24, in the Appendix. 
Tis.ue hOlllOleni.er ... The rat livers were hOlllOleniaed 
in a homopniaer of the Potter-Elvehj_ type which consisted of 
a smooth 11... tube and stainl .. s .teel peatle with & I8P of 
approximately 0.5 am between the pe.tle and tube. 
ME'1'RODS 
lERHltlO1\ of liver MEMI.tg - Livers .... obta1a.ecf 
froa rats w1ahiDa apprexiaatel, 200 p .. which were sacrificed 
1t1 decapitation. The livers were blotted t w1Jhed, aDd arouad 
._tlyat 700 r,. for one to two .iIlute. with 2.5 vol .... of 
p 
PIGURE 10 
RADIOCHRCltATOGRAM OF MEVALONATE-2_C14 
so 
Chromatographed aa the salt of N,N'-dibenzylethylenediamine. 
The developing ao1vcm.t was ethanol:NR40H:water (8:1:1 v/v/v). 
Full scale deflection: 30,000 cpm. 







phosphate buffer (0.1 M. pH 7.4) (59). Unbroken cell., ti •• ue 
debri., and the mitochondria were .1ia1nated by centrifuaation 
at 10,000 x , for 30 minute. in • Spineo Ultraceotrlfuse (Ieo~ 
Instruaent. Inc., Sp1llco Divi.ion, Bel.moftt. C.lifornia). Th. 
entire proce •• vas carried out .t oOe. TIl. homo, __ te. thus 
prepared vere useel 111 obcainilll the eDa,.. .,.t_ nec .... ry for 
chole.terol bio.yatk •• i. fro. mavalonic acld. 
lr!parttMi of ~, au •• utS • th. oOlll)in84 pro-
e.dur .. of Popjak .11 .11 •• (118) and Popjak (184) vel" u.ed lor 
the prepara.tion of th. eo.a,... nec ••• ary for the blo'yI\tA •• i. of 
chole.terol from mevalonic acid. Th. 510 fra.ction pr.pared as 
ahoY ..... c_trifuaecl at 104,000 x I for 90 aiaute.. The Sl04 
,upanlat .. t va. pipetted off. c.r. lite1a.a talt_ not to di.turb 
the .ad~ted particl ••• 
Th ••• dla_t It wlaicb contain. Idero..... va. r.aua,.uled 
in a volume of buff ..... 1 to aboc _ ..... t.r of the oriaJ,aal 
vol_ of the 810 ad •• cu._ted .. ata at 104,000 x a for 90 
ainut... 'l1d .. tiale the .u,....tant ... di.carded and the washed 
aieroac.a. wer. cll1at... to 0.1 voluae of the 110 •• punatat from 
which th.y ........ eparated. The mero .... thu prepared were 
k.pt at -15oe _til ... d ill ca •• par __ t •• 
p 
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The supernatant from SlO4 was satu.rated with solid 
(IDi4)ZS04 (6.3 ,/10 ml of supernatant). The precipitate w.s 
filtered off overnigbt at oOe, dissolved in 0.02 M KHOO3 (12 .1/' 
g of precipitate), and dialyzed for 3 hours against 0.0% M KROO,. 
The dialyzed solution was then fractionated with (NH.) 2804. lbe 
precipitate obtained fro. 0-301 .aturation ... diacarded and the 
solution ... s.turated to 601 (NH4>2S04. The precipitate obtain 
after the second precipitation vas stored at -1SoC until the day 
of the aper1ment, 'tIlten the precipitate was apin dissolved in 
0.02 M 000, (12 al/3 I of precipitate) and dialyzed for 3 hours 
qa1nat 0.02 M moo,. 'lb. dialyzed material vas then treated 
vith protadn. sulfate (2 ma/m1) and tbe precipitate that was 
obtaiDed va_ discarded. The supemataDt vas uaed ill the experi-
ment. .. • sourc. of soluble _,... aDd will De referred to a8 
"dialyzed .olu1>l. eaa,.... fI 
lb, procedur .. uaed for the i.olation of the •• ,.. 
.,.t. are.. .riaed ill Table ,. 
'A' "'Mlt!S lIi.surl • Each iDcubatiora v •••• l ccm-
eained 1.0 IIll of dla1yud .01ub1e ._yme (17-21 .. of proteta). 
0.02 IIll of microsomes (7-11 .. of protein), 1.0 ml of substrate 






FRACTIONATION OF LIVER ENZYME SYSTEM. 
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dialyzed; solution treated with 












up to the synthesis 
of famesyl pyrophosphate 
The volume .... ..de up to 4 .1 with phosphate buffer. Th • 
• ub.~rate solution contained 2 .icromale. of NADH, 1 micromole of 
NADPH, 30 Ddcromole. of ATP J 30 micrOllOles of GSH, 4 IDicroaaole. 
of Mn++ and 1.0 adcramole. of DL mevalonate-2- or _l_Cl4 
(0.37-0.74 microcurie. of C14) in one ml of phosphate buffer 
(0.1 M. pH 7.4) containing 16 micromol •• of M'·~ and 0.03 M nlcot 
inamlde. 
The protein contain.d in the microsome. and the 
dialyzed soluble fraction was measured by the biuret reaction 
(64). the d.scription of which i. aiven 10 the Appendix. 
Incubltiggs - Studi.s on the incorporation of 
mevalonate-2-Cl4 into the non-saponifiable lipid were carried out 
a .• robica1ly in an Elmac metabolic shaker (Elmac lmgineerins Co •• 
Chicaso, Illinois) at 37°C. The oxygen was introduc.d into the 
incubation v .... ls by a s.rie. of TySon tub ina sections into 
each lDdivi4u.al v •••• l. In studies 10 which CO2 was det.rmined. 
the oxygeD served a dual purpose 10 that it "as also used for 
fluahtna the c1402 that was produced. The radioactive carbon 
dioxide was collected in pyrex test tube. containing lO~ IOH 
solution. After the .pacified incubation period, the reactions 
wera uaually .topped by the addition of l .1 of lS~ KOR in 504 
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TABLE 6 
COMPOSITION OF THE INCUBATION MIXTURE IN THE BIOSYNTHESIS 
OF CHOLESTEROL PROM MEVALONATE_2_C14 
1.0 .. lot' soluble enzymes precipitated between 
30 and 6~ saturation with (HH4)2S04. 



















All in 0.1 M phosphate buffer. 
pH 7.4 
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.thanol to each incubation v .... l followed by heatina for 10 
adnut .. at 37°C. In incubation. wh.r. only the radioactive 002 
vas deterained. the reaction. were .topped by the addition of 
0.5 .1 of concentrated sulfuric acid. 
'!olltion IDd extrlction of nOft-!!P29if~l. lieid, .. 
The partially .aponified reaction mixtures were transferred to 
2S .1 screw-capped culture tub... the react10n ves •• l. were 
rin •• d with 3 .1 of the a10OOol1c KOH solution and the riDSe 
added to th. contents of the culture tub... Saponification .a. 
completed by heatin, tbe tl&htly capped tub.. in a water bath at 
7,-aOoe for one bour. The saponified reaction mixture. were thaD 
cooled and extracted four times with 10 .1 portiona of lilht 
petrol~ ether (30-60° hollins fraction). This solution con-
tained the total non-sapcmifiable lipid co.posed of all the 
tnter.ed1a~es of chol.sterol biosynthesi. from squalene to 
chol"'erol. iDelusl.el,. 
In experiments in which only tb. chole.t.rol v .. 
deterained, the petrol .. ether v .. evaporat.d to dryn.ss in 
heavy-duty centrif",e tubes. The re.idue "as dissolved in 3 101 
of acetone-ethanol solution (1:1 v/v), and 1.0 .. of carrier 
cho1 .. terol :I.D o. S al of ethanol was added. The 3-beta-bydroxy 
--
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atero1. were precipitated by the add1t1oD of 7 .1 of 0.'1 
dilit_in in SOl ethanol. After atandiDa at rOOlll teperature for 
16 hour.. the dilitonide precipitate ... recovered by eentrifu-
aatlOft. ...hed once with 901 ethanol, OI'lCe wlth acetone. O'OC. 
with acetone-.thar (1:2 v/v). _d fiDally with petrol .. ether. 
In experiment. in _1ell Nth the choleataro1 ad total DOD-
.aponifiable l1p1d were deter.tDed, ooly a aultable aliquot of 
the petrol .... ether extraot va ..... ed for eboluterol detera1na-
tiona 
l,oA.t1op of the "",enol fr.etlga - !be isolation of 
the 1aoprenol.. pre-.qua1.e branched oba:l.a a10oho1 int..-diate. 
of ob.e1 .. terol. was done by the _cbocl of Popjak (116). 1'be DOD-
.apora:lfiab1e lipid fract10D v.. partitioned iDto petrol_ ether 
froll the alka11ne 1Dc:ubatiora a1xtuJ:e aftar .aponification with 
mB. The a~ 1' .. 1 .. _. th.acidifled to pH 1.0 with 
HalO 4. After the .olution had .tood at roo. t..,.-ature for eme 
hour. the pH ... readjusted to 10.0 - 12.0 with lOR _41 th. 
lsoprenol-c14 s.stac.. were extracted four t .... with petrol .. 
ether aDd the activity cteterm1Decl iD a .cintillation counCeI'. 
ldtBSilicatlop 01 ChI i.oprepol_C14 .ub!~!pc.. - Thi. 
vas don. by rever •• phas. paper cbr .. top'aphy of the 3.S-d1Dltro-








ISOLATION OF CHOLESTEROL IN''tEIMEDIA'l'ES 
INCUBATION MIXTURE 
aaponified (15~ ale. KOH), 2 hr •• 
at 75°C. 
I 
Extract with pet. ether 
I 
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Petroleum. ether extract Aqueoua pha •• (iaoprenol-PP and other cpds) 
acidified to pH 1.0 
with H2SO4 













and kept at room t&mpel"ature 
for 6 hours. made alkaline 
with KOH to pH 10-12 
f 








by the .. thocS of Cherooi. ad IDtrlkf.n (33). Th. petroleum .ther 
fractious .. obta:lned above ...... aporated to a vol ... of on. 
1I111111t... To thi. 1 .. of •• ranl01. fane.ol, act .ero1idol, 
r •• pectlve1y, 40 III of 3,'-d1n1trobelUloyl chloride (recr)'.ta1-
11ud fr. CC14)' , .1 of taoprop,l .th.r (fr .. frOID alcohol), 
ancl OD. drop of P7I'1df.ae .... ackIed and the a1xtur. ... r.fluxed 
for two hour. ill a .. ter bath at 10°C. 'lb. tub •• were then 
cooled ad the CODt_C_ ... bed 0I'lC. with 4 .1 of dilute .ulfuric 
acid (21) to remove th. pyridin., 0I'lC. with lal KaOH, _d ODe. 
with vater to resaov. the 3,,-d1D.itro'benao1c acid. 'lb.. ether 
layer thua Obtailled .... waporated to drynes.. !be r .. 1du .... 
di ... lv.d in 0.2 at of chlorofon aact 100 meroliter. ... tbeD 
.treaked OIl WhetMD Ro. 1 fl1ter paper iaprepated with 101. 
lliDeral 011. Th. chroaat0p'- .... the placed In a chrOllato-
P'aphy jar aacI ecaul1ibraticm .. _ allowec1 to take plac. ov.nlpt. 
The .trlp. wer. then developed for 12-16 hour. vith 7" acetic 
acid. 
scrip. of _til_tie • ..,1 .. of 1 __ 101, fam .. ol, .. 
.... lido1 .. the 3,'·d1DltrobelUloat .. (prepared .. &boY.) vera 








After the c:hroraatoaraphy, the strips were dried. 'l"he 
non-radioactive derivativ .. were stained with '1 naphtholaaine. 
The JIOVeaent of the derivative •• _ revealed a. dark oranae spot •• 
Th. radioactive strips ware scanned for radioactivity and the 
compounds Identified by comparison to the sov..ant of the 
authentic samples of the alcohol.. Fiaure 11 sbowa the movement 
of the authentic sampl.s of the alcohols in the ayst.. used. 
Geran101-3,'-d1nitrobenaoate save an Rf value of 0.64, 1dt11e 
farn .. ol and nerolidol-3,S-d1nitrobenaoat .. had ideatical af 
values (0.32). 
Xaolltis of .gualg - Tbis .as done by the method of 
Lanaclon and Bloch (86) by cbrcaatoarapby of the non-saponifiable 
lipid fraction on alumina colUIIDa 6cm high and one em in d1a8eter. 
Squalene ... eluted with 100 .1 of petroleum ether after which 
chol •• terol ".. eluted with SO .1 of diethyl ether _ !he squalene 
fraction waa then evaporated to 10 .1 and one .1 of this solution 
.as put directly into 10 .1 of scintillation solution aad counted 
in a scintillation CGUllt_. t'be cholesterol fraction vas treated 
in a .1af.1ar -,- Part of the fraction ... further character1Hcl 
by precipitation with d1ptonill aDd determf.aat1on of the 
cboleaterol-d1l1tonide in a ... flow counter. 
---
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CHR<»IATOGRAPHY OF IS OPRENOL-3, 5 ... DINITR.OBENZOATES 
Reverse phase chromatography on Wha.tmcm. No.1 paper impregaated 
with lot. medium nd.neI"al oil. The developiag solvent was 7ft 
acetic acid. 1 - geraniol (RE _- 0.64); 2 - farneaol (Rf • 0.32); 3 - nerol:l.clol (I. • 0.34); aM 4 - .ixture of germyl, fames,.l. 
and nerolidyl-3.t.d.initrobenzoates. The origin is at the top; the 
solvent front at ~. bottom. Developing time: 12 hours. 
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~asur!!,nt of radloactiv1tx - The radioactivity in 
the non-saponifiable lipid, isoprenol., squalene, and in some 
cas •• cholesterol, was determined with a Trl-Carb Liquid 
Scintillation Spectrometer (Packard Instrument Co., Inc •• La 
Granl •• Illinois) with the photomultiplier tube voltage set at 
1020 v and a discriminator setting of 10-100 v. The ccapolition 
of the liquid scintillator which met the criteria of the hiSheet 
counting efficiency was described by Bray (42) and consisted of 
60 P of naphthalene (recryata11iaed frOID alcohol, lot INX S) 
obtained from Mathe8OD. Coleman. and Bell Co •• Eaat Ruth.ford, 
Nw Jer.ey; 4 II' of toluen.-2,S-diphenyloxaaole (PPO. lot 121002) 
and 0.2 .. of 1,4-dl-2-(S-phenyloxaaoyl)-benaene (POPOP, 
Scintillation Grade, lot 12023) obtained from the Packard 
Instrument Co., Inc., La Granse. Illinois; 100 al of absolute 
methanol and 20 ml of ethylene alycol dissolved in p-dioxane 
(Spectroqua1ity Reqent, lot 'OX 2095) obtained frOli Math •• on. 
Col __ • and Bell Co. t to ... one liter. T_ ld.lllllter. of 
thi. .cintlll.tloD solution was added to a COUfttiq vial coa-
tainiDl one ailllilter of the active petroleua ether solution 
that was to be detel'1lliDed. 















a= Cl. 0.2 
LL en 
4 8 12 16 20 
mg/cm 2 
FIGURE 12 
SELF-ABSORPTION CURVE POi. BaC1403 
Reproduced f~OW the formula 1/1 == 1 - e-~h/~. where ~ • 0.29 
and h == mg/cmI' of t"he plated miterial. Wmtrogham., J. "Radio-
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a:: Q. 0.2 
lL. en 
4 8 12 16 20 
mg/cm 2 
FIGURE 13 
SELP-ABSORPTION CURVE POR CHOLESTEROL-C14 DIGlTONIDE 
Reproduced from: Da1idowicz, J.E., Thesis, Loyola 
















were determined with a Tracer1ab gaa-flow a •• embly consisting of 
a FD-l ga.-flow counter (MOno-~~l-Resin Window); a SC-83 scaler. 
a Se-100 multi-matie sample changer; and a SC-5E timer (Traeerlab 
Inc., W.lth_. Ma.sachusetts). Self-.bsorption correction. vere 
mad. on all solid • ..,1.. froa the •• 1f-absorption curves for 
BaC1403 and cbo1 .. tero1-C
14
.digitonide Jiven 10 Fiaure. 12 and 
13, respectively. In both acintillation and ps flow count1D&, 
a sufficient DUBber of count. vas taken to reduce the atatistic.l 
error of countin& to l .. s than s~. 
1.'be .CaDIl1n& of r.diocbrOllatoar_ •• clone by the 
SC-S' Cbromatosram Scanner .ttached to • tr.eerlab Preci.lon 
R.t_ter (Tr.eerl.b IDe., Waltha, M .... chu •• tt.) and recorded 
on a Rectilinear Recordl .. Mi11i_tCir (Texaa tnatruaanta Inc., 
Houston, Texas). 
THE SID OF THE IN VITRO INHIBITION OF CHOLES'l"EROL 
BlOSl1l1'HESIS BY HYPOGLYC.DllC COMPOtnmS 
It bal been reported that pbenethylbiauanide, tolbuta-
iii •• _tabu_id., and chlorpropamide inhibit chole.terol 
biosynthesia fro. acetate-l-Cl4 (43) (44) (45) (100) in liver 
~pnat.s prepared by the method of Bucher (59). lbe results 
1ndlcated that the max:laum inhibition with any particular 
bJPOalyc_lc COIIpOUlld was obtained what the concentration of the 
inhibitor wu 4 x 10.3 M. 'lb. 1nh1bitlon of the total non-
aaponifiable lipid, however. was not the .... for each hypo .. 
,lyc.u.c compound. Phenethylblguanide, aa compared to the three 
aryl.ulfODylur .... decr .... d the incorporation of l&cetat .... l .. C14 
into the non-aaponif1.ahle lipid to a much areater extellt. The 
inhibition was approxiDlately twice as -.u:h .. that obtail."led with 
either tolbuta.1d., uaetahuamide. or chlorpropamide. Thi. was 
the first indication that phenethylblguanlde had an effect on 
choleatuol biosyntheaia quite different from that of the 
.ryl~lfonylur .... 
When the :i.ncubation mixture., after saponification aDd 
extraction of the non-saponifiable lipid. were acidified with 
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H~4 ad the readJueteci the pH 10.0 with lCDH, thera ... _ 
iller.... 1a the oaltral-C14 labeled .... taDc.. ill a1xtur.. eon-
taiaiDI tU hypo.17c.te cwllpOUDCla. Ttl. 100r .... 111 the bacor-
,oration of acetate-l-C14 lato the aeutra1 cOllpOUDda was the 
... for ph.-thylbS..,.ld .... for the aryl.1,l1f_ylur_. 
S1ace _.at .......... the precureor of eltol .. tarol, 
tha nature of thea. e..,.... could DOt 'be .. cartatud. Alt1uN&h 
t .... l iDt .... dl.t... the fonatloD of other Ca.pouacll 18 poe.lbla. 
It ... decided t ther.for.. to ... ..,,&1_10 acid, a .ora direct 
precurlor .f cbol .. terol tIuID 18 .etaee (54) (141) (153) (1S4). 
iD the elucldatioll of tile alte of lahlbltloa of chole.c ... l 
b1081fttba18 b,. the h"..ly ..... c oOllpoua4a • 
.... lODia acld ia net oal1 a .... direct. precurlOl' of 
abol .. ter.l, but alao a cOllpeuacl 1Ih1oh II DOt lavolvecl 1a a,. 
other -Jor _e&holic pattnrq. !hI. face leacla to _re 1a-
t .... t1D& ... aaiflcati_. llweatipt .. a ia th. fial. of abol.l-
tarol bio.,.chel18 have fOUl'lCl that the radioactiv. CGIIpOUIlda 
fomad iD 11ver ....... t .. or ..,.. a,le_ fr. MYal_c.-2-
C14 are lat __ dlat .. exc1ualv.ll' &I_lated witb cbo1eatenl. 
!hil __ I that when th. total .... - • .,..II1&bl. l1pid 18 
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detU'IIiDeci. the radloactivlty 18 due to chole.terol 1atermedlat .. 
fro. .qual.ae to chole.terol inclustve and is devold of an, other 
radloactlve CCBpOU1lda. Asaln, _. the aeutral compouads .e 
Isolated. the 0111, on .. that COIltaiD any radloactivlt, are 
dimethylall,l alcOhol, .e .... lol. and fame.ol, all 1ot~dlat .. 
of chol .. terol. 
'l'be us. of ...,alOllie acid alleviat.. the baurds that 
would be iDeurreci lf acetate .. uaed, e.l*=lall,. v:l.tb whol. 
liver ~a-t... Ia fact. the .. j07: fate of acetate ia otber 
tbaD lts iDoftpo .. at1oa :Lneo choleatero1. 
Altbouah lt vas stated tbat .... lonlc acid ..... DOt 
eocu ., otber major .. tallo11o pathway buid .. ob01 .. t8l'01 
bioaynth .. is. It ia metahollHd to other c..,OUDCIa _t direotl, 
iavolved la t:U bto.yntbuis of cb.ol .. cerol. R.ec_tly. _idale. 
baa bMD obta1Mcl by ~l.topIae ed PopJak. (34) that 1a the liver 
... ,.. 8,.ac_ that 18 to be used in thi. tnveat.laation • .ev.lemat 
ia • precuraor DOt OIll,. of squalae IIIlCI chol .. t.erol but al.o of 
certain plWlO1c acids. !bese acida are fol'MCl Ity a •• cbani. 
~let.11 dlffer.t fro. that of 8,.tb .. ia of norul fatt, aclda. 
It coa.aiat. of the dephoaphor,lation of all,l pynpboapbat. .. 









debydroaenatlon of the re.ult1na prenol. by liver alcohol de· 
hydroa.". aDd aldehyde deh7dro,enaae iDto the corr .. pondina 
acids. the relationshlp of th .. e compound. to the other metabolic 
pathway. and the function of th... acld. in metabollsm 11 .till 
unkDown. 1!hia fate of .... lonic .cid. however. :La couid.-eeI to 
be a aiDOr one •• lthou.a,b ,rob_l,. aot .. UIliIIport.aDt on •• 
Th. fOl'Mtion of til ... cOIIpOUDd. fra. .v.lonic acid 
doe. not lead to erroneoul interpretatlon of the d.ta obta1nad 
with .valOl1io acid. The laolatioa of the 1Io,r8l101c .clds 
involv .. extraction from ell .cidic .-d1ura. SiDe. the ilolation 
of the 1Dt ..... iat .. of ohol .. terol involv.. auractiou from 
Mdia other thaD acldic. tbe lIopraoic acidl have 1\0 effect OIl 
the radioactivity of chol .. tarol 1DterMdiat... Meval_io .cld. 
tb.ea» i. ...11 suited for tha Icudi.. OD the lit. of iDb1b1tlon 
of chola.t.-ol blolynth .. ia 'by the hJPOllyce1c compound_. 
~Icr or HDOGLYCIMIC 00MP0UlU)S OR TI1I DCOUOMTIOR OF MVA-2-
C Ilft'O TBI BON-SAPONIPlABLE LIPIDS 
Table 8 ebowI that tolbu~cleJ in CODceatr.tiona Imown 
to inhibit the 1DcorporatioD of acetate-l-C14 iDto cholesterol. 
a1ao 1nbibita the fo~t1oa of chol.lterol froa mevalonate-2-C14• 





EFFECT OF TOLBUTAMIDE ON OHOLES'fEROL BIOSYNTHESIS 
FROM MEVALONATE_2_C14 
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Conditions: Each flask contained 1.0 ml of dialyzed soluble 
enzymes (i7.5 mg of protein); 0.2 ml of microsomal preparatiOl'l 
(10.2 mg of protein); NADH (2 pmoles)j NADPH (1 ~1e); ATP 
(30 iJ.1IlO1aa); reduced glutathione (30 (.&IIOles); MgC12 (16 ~1es); 
HnS04 (4 iJID01es); and mevalonic acid ( 0.5 &J.lU01e, 0.25 1J.C of 
0-14). Aerobic 1acubationa at 37 C for two hours. 
Cone. of Tolbu.bltide 






























add. and attaina a maxi .. (SOl) what tolbut_We i. preaent ill 
the incubatioD Idxtur.. in conceotrat1.ona of 4 x 10.3 or h1&her. 
Thi. is 1O-1.5t. lower tharl va. obta1rled _eo acetate-l-C14 aDd 
Bucher ~a-t •• vere used. The COIIpC'laon of the 1Dh1bitiOll 
of cbo1 .. tarol hiosynthesia from both acetate-l-C14 and 
.."aloute-2-Cl4 b1 tolkt_de 1a liv*, 1n F!pre 14. 
Altbouah pb ..... thylh1&u_id. 18 different frOil tolbuta-
mele in lta atruct.. &Ilel h"o,lyc.uc action, the effect of thi. 
cQlpClUDd OIl ch01 .. ten1 bioaynth .. s.a from MYel .. t ... 2_C14 1. 
approd .. tely the ._. raltle' 1ndlcatea that pheaethyl1d.pa-
D1de 1Dh1hlt. the 1DcorporatioD of _va1onate-2-C14 iDto cho1 .. • 
terol. 
The iabibitioD ill 0_,.81e to tolbat .. de iab1bit1on 
:I.uofar .. the max1aa ... obtalDed with OODCeDtratioaa of 
4 x 10.3 K. III re.pect to the ...,itude of the lDld.'b1ti.oD, 
~. the ~.t1oD of ..,.loaate-2-C14 mto c:bol .. t .. ol 
__ ph..chyl1:d ..... U. 1. pr .. .t in the .JDtb .. iII1a& .,.t. 
ia hiah" (10-151.) tn. __ tol'but..tde 18 ,r ... c. Tbi. ia 
oa1y true __ Cbe OODc_trac1oD of the part1cular hypoalyo-.1c 
c..,... reachu 4 x 10.3 M. III CODCeDtratiou 10nr tha 
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CONCENTRATION OF TOLBUTAMIDE (MIlIOI) 
PIGURE 14 
COMPARISON OP TftE EFFECT OF TOLBUTAMIDE ON THE BIOSYNTHESIS 
OF CHOLESTER.OL FROM ACETATE-l-C14 AND MEVALONATE_2_C14 
Conditions: For aeetate ... l-C14 - each flask contained 0.5 ml of 
rat tIver homogenate (600 U\g of liver); 1.8 pmoles of NAD and 
NADP, respectively; 3.3 iUDo1e. of ATP; and 20 ~ole8 of acetate 
(0.5 ""C of 0-14). For mevalonate-2-0-14 - the conditions were the 
.ame as in Table 8. Aerobic incubations at 37·0 for two hours. 
Each point is an average of five experiments run in duplicate. 
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TABU'! 9 
EFP'ECT OF PHENETHYLBIGUANtDE (lit atOLES"lEROL BIOSYNTHESIS 
FROM }fiWALONATE_2_C14 
Conditions: the conditions were the same as deacribed in Table S. 
I • 
Conc. of PbeJ\ethylbigwmide Cholesterol ~ Inhibition 




0.5 1,102 28.5 
1.5 1.224 48.6 
3.0 832 65.0 
4.0 528 77.8 
5.0 556 76.6 
6.0 524 77.8 
p 
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cholesterol bioaynth.a1a to .pproximately the s ... extent 
(F1pre 15). this is in contraat to _at vaa observed with 
acetate-l-C14 a. the precursor of eRole.terol. In the acetate 
syat .. , pbenetbylblauanlde inhibited the incorporation of 
acetate-l-C14 into cho1 •• terol to a Id.per dear .. than did 
tolbut.-1c:1e. 
Apin, .s .aa observed with to1buta1de. the max11lla 
1Dbibitioft obta1aed with phenethy1bisuanide Wben aeva1onate-2-C14 
was ",eel .. the star-tina .. Cerial is lover than 1ItIh. ac.tate .. s 
uaed (J'iaur. 16). In c.traat with to1bu.t_id •• the L.1bit1ou 
... 20l loRr, or twice as much .. the deer.... 10 1Dhiblt1on 
obta1Ded with tolbut_ide __ .... lout.-2-C14 and acetate-l-
e14 are COIIp ...... 
Wben th. tot.1 aoca-aapoa1f1ab1. lipid ... d.terat.Ded, 
it v.a found 'that tolbut.tde, ch1orpropaaide. ad _tah __ ld. 
(2.5 x 10-3 K) bad practically DO .ffect OD the lacorpol'atioD of 
JlllYaloaau-2_e14 iDeo the raoo-aapc:tIlifiabl. lipi.d fraeti., but 
the fomat:l.Ola of cllol .. tenl ... atill .. 'r...... a.-layl-
~"'._lde (2.5 • 10-3 )I). _ dua 0CIa_ 1aaDd, iDbU,it" the 
1DcorporatioD of .avaloaate-2-e14 iDto both claol .. , ... l aDd tbe 
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CONC. OF HYPOGLYCEMIC COMPOUND (M)(IO
S ) 
FIGURE 15 
COMPARISON OF THE INHIBITION OF CHOLE..<)TEROL BIOSYNTHESIS BY 
TOI..8U'tAMIDS AND PHENE'1'RYLBIGUARIDE nOM MEVALONA.TE_2_C14 
conditians: the conditions were the aame aa described in Table 8. 
~lo.ed ctijl~! IDhibition by tOlbutamidel- !p!u circlea: lDh. i-liii"iia"Di phiiiithylbi~nide. Each point: a an iverage of fi". 
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CONCENTRATION OF PEBG (MxI03) 
FIGURE 16 
COMPAP.l3ON OF THE INHIBITION OF CHOLESTEROL BIOSYNTHESIS BY 
PHENETHYLDlOURIDE FRCItt ACETATE_i_e14 AND MEVAl..O.NATE-2_C14 
Condit1oua: the conditions were the aame as described in Figu.r:oe 14 
Each poriit 1& an average of four exreriment8 run in triplicate. 
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extent as shown in Table 10. 
Popjak .. .11. J (115) and Lan&don and Bloch (86) ..-n& 
others have found that the no~8aponlf1abl. lipld contaiDa all 
the cboleaterol iDt8t'Bl8Cliat.. frOID a.alena to cholesterol 
iDclualve17. Alao. 1f mevalooate 1. U8ed .. the precur.or of 
chol .. terol bioe7DtluI.1a. the oral,. raclloactlve CCJIIP'OUl'lds pna_e 
1a the .... sapon:1f1able 11p1d fraction are cholesterol inter-
mediat... the htaheat amount of radioactivity appear1D& in 
aqual.e. the 1acorporatlOl'l of mevalemate-2_C14 toto the DOD-
.apooiftable fraction. therefore, could be taken .. an .. twee 
of _qual .. s7Dthes1a • 
Ie would ... fr. the r.sults obtained 10 Tabla 10, 
chat the uyllulfonylurua do DOt bahibit .,It of tha iDter-
.. lat .. of chol .. t.erol 1alolyoth .. la cOllta1ned in the GOD-sape"d.-
fiable lipid fraction. Pheutbylld.panlde. however. .... to 
1Dhl'Dlt the fonation of 1101' lnt._ecU . ac_ of ohol .. t.uol la 
thia fractloo t.o approdMtely the s_ extent as ahOWD by the 
..... , of chol .. terol foe.. and the incorporation of ..valonate-
2_Cl4 into the non-saponifiable lipld. 
Taktna the radioactlvity in the ftOD-saponifiable I1pid 




EFPECf OF HYPOGLYCEMIC COMPOUNDS ON THE INCORPORATION OP 
MEVALORATE_2_014 INTO THE NON-SAPONIPlABLE LIPID FRACTION 
ConditiOha: the conditions were the same as described in Tab~ 6. 
The 'concentration of all &ypoglycemic con:apounds was 2.5 x 10- H. 
Aerobic tDcubatioaa at 37 C for one hour. 







TOLBUTAMIDE 73,860 5.0 
CHl..oRPROPA-
MIDE 71,060 8.6 














lated that the inhibition of cholesterol biosynth •• is from 
mevalonate-2-C14 by phenethylb1&uanide should take place before 
the formation of 8qualene. l'he inhibition of cholesterol oio-
ayntheais by the arylsulfonylureas. on the other hanel. should be 
after the formation of aqual.e. 
To tut the above hypothesu. the first of the experi-
ments performed to elucidate the aite of the inhibition of 
chole.terol b1osyoth .. la by the hnoilyc.u.o cQlBPOUDda, wa a 
study of CIte effect of thue cOIBpOUDda on the first thr.. steps 
of cholesterol a1fttheai. froa aevaloaate. 
CarboD-l of .valonic acid 1. lost .. CO2 in the path-
way to choleaterol by tbe formation of iaopentalyl pyropb.o.phate. 
If aval_ie acid ... to be labeled in the l-position. the radio-
active carbon dioxide obtained fna the incubations would aerve 
as aft 1ndicat1ou of the formation of uopentenyl pyrophoaphate 
and the reactlou that prececle it. 'l'hia in effect would indicate 
whether or DOt the hypoSl,c.uc COIDpOUDda bad .y effect on the 
fomat:l.on of 5-pho.phoaevalonate. 5-dipboaphomeva1onate. and, of 
cours., laopeDtat,l pyropboapbate. 
10 
Mevalon4te-l-C14 ... therefore incubated with 1.0 .1 
of the dialyzed .olubl ... yaea, ATP, and the hypoalyc.u.c com-
pounds in concentrationa known to inhibit the bioaynthes18 of 
Cholesterol almost completely. Microsomes and the other cofactor. 
nee.sury for chole.terol biosynthesis vere not uaed since they 
are not: aeetled for the fol'llAtlOD of iaopeatenyl p)'rOpbo.pbate. 
Tal. 11 ahow that none of the hypoalyc.uc cOllpOUrlds that were 
used :I.n the inveati&at1on had any .ffect on the decarboxylation 
of mevalonate-l-C14 as measured by the r.l .... of radioactive 
carbon d1ox1de. The ruulta of thia exper:laant indi.cate that 
the bloa1Dtbea1a of choleaterol is DOt interrupted before the 
formation of laopentenyl pyrophosphate by tolbutaicle, chlcn-pro-
~de. or phenethllbiauan1de. 
TD J1ICORIfOIt.A1'IOlI or MlVALOMU-2-C14 urro THE lSOPUllOL nao-
PHOSPHATES AND RELATED OOMPOUNDS 
After ineubat10n of lHValonate-2-c14 with the neceaaar, 
cofactora aerobically. the iaoprenola, pre-aqualene braached 
chain alcohol intermediate. of choleaterol, were iao1ated hy the 
method of Popjak (116) given in the previous chapter. The re.ult 
in Table 12 ahow that one of the hypoalyc.u.c compounds, 






EFPEC'J.' OP HYPOGLYCEMIC CCH?otJNDS ON THE DECARBOXYLATION 
OF MEVALONAn-l-C14 
Ccmditi01UJ' Eaeh incubation flask cOfttained 1.0 ml of dlalyze4 
solu61 ... ,... (16.4 nag of protetftl, 10 ...,1.8 of A~ t a'Dd 0.5 
paole of .. alO1Ul~. ('87,000 cpm). 't~ ccmcentration of the 0 
hypoglycemic eompouads was 4 x lO--:M. Aerobic incubationa at 37 0 






pmolea of e14 







EPFEC1' OF HYPOOLYODf1C COMPot:JHOO Ott THE FORMATION OP 
ISOPRENOL PYROPHOSPHA'l'ES FROM MEVALONATE_2_C14 
Oonditicma: the COI\ditions were the aame &$ described in Tab~ 8. 
S acmeeavation of the Itypoglycetdc cOl'lpOUl\ds was 2.5 x lO- 1,1. 
























isoprenol fraction. Tolbutamide, chlorpropamide, ana _tabexa-
mids. on the other band, had no effect on the incorporation of 
mevalonat .... 2 ... C14 into tMa fraction. 1bi. WaG not an unexpected 
reault, a:i.nce :i.t was postulated that phenetbylbigu.an.ide 1nh1bits 
chol •• terol biosynthesis before the forut1on of equal.e, while 
the arylaulfonylu.reaa 1ah1bit aft.. Che fcmaa't101l of 8flU&l.ao 
!he ruulu in Tabla 12, therefore, comply with the hypotheau. 
l"he fiDal proof of tills postulation would be to show Ii decr .... 
in the format1oll of _Qualm. w1th pheoetbylbisuaD1de wlUle 
ohtaiumg the ... format1oD of squalene with the uylaulfonyl-
ur .... 
10 t:be elucidation of the pathway of cholesterol 
b1087Dthu1a. PopJak.lS.&1.. (11.5) fouad that __ 1D~ioIUI 
c:oDta1Diaa all the cofactors nec ... ary for the, formation of 
choleatarol ... e 1ncubaed aerobically 10 the prueoce of re-
duced alutatb10De (GSH) both equal .. and cboluterol were 
ayntba1aed from lleValooate-2_c14 • In the ab ... ce of alutaCh10De 
and in the prea.ce of oxygen. howver. neither squalene nor 
cholesterol waa formed. OIl the other hand, UDder a nitro_ 
at:8Jsphere, aqualeD. V&8 8yathea1aed as efficiently in the 
absence .. in the presence of alut.ath1oae. 10 fact, squal .. 
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waa the ooly radioactive intermediate formed in the non-saponifi-
able fraction wben incubations were done anaarobically. Anaero-
bic incubations. then. stop the b10synthetic pathway of chol ..... 
terol at tba .formation of squalene. 
In order to teat the hypothesis that the 1nhib1t1on of 
<:bol_terol biosynthesis by tolbuta1de takea place before tbe 
forutiOlt of squalene. wh11e the inhibition by phenethylb1panide 
after the formation of aqualene. similar incubations were made 
with the h7PO&lycem1c compounds. After the specified period of 
reaction in a nitro&en atll1Osphere. the non-saponifiable aubstan ... 
were extracted .. deacr:l.bed previoualy, and the squalene vas 
separated from the re.t of the non-saponifiable lipid by ahml1u 
c.hromatoaraphy. the resu.lts in Table 13 abow that the fcn:aatlOll 
of squal.ut 1n the preaenc. of phanethylb1&uan1de vas substan-
tially :l.ahibited. In the preaence of the arylaulfonylurea eGa-
pounds (tolbut.ude and chlorpropamide). however. the formation 
of ..... lene was the ... as in incubationa that contained DO 
hypoalyc-.ic compound. 
To teat that squalene 18 the actual compound tb.at was 
obtained, the elu.ted sample. were further characterized throuch 
the thiourea adduct. To the chroaatoaraphed specimen. after 
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TABLE 13 
EFFECT OF HYPOGLYCEMIC C(»IPOUNDS ON THE BIOSYNTHESIS 01' 
SQUALENE FJ.\OO MEVALONA'l'E_2_C14 
conditiO'hS: the conditions were the same as described in Table 8 
with t'tii exception that no glutathione was present and that only 
0.15 ""C of 0-64 was used. Anaerobic ineuba:tiona (ninogen atmo-




















evaporation of the solvant, a few ailliliters of a saturated 
methano11c solution of thiourea, a few araina of finely powdered 
t.'liourea. and 10 tUg of carr iar squalene va added. After thor-
ough. shaking. the mixture waa left at room taaperat.W:"8 for a f_ 
days. lb. crystals of the clathrate were then filtered and 
decomposed with water t the squalene extracted with petroleum 
ether. and counted in a scintillation counter. 
From the reaulta in Table l3 it can be seen that there 
was no appreciable 10s8 of radioactivity after the aqualen .... 
taken throuah the thiourea adduct. 'I'he coapouw;I that was actWl11, 
be1nS eluted by petroleum ether from the alumina columna aad 
assumed to be conaiatina of only squalene waa indeed equal_. 
The 8ame table shows that asain pAaoethylbiauanida ... in incu-
bati0D8 that ware allowed to proceed to chol •• terol, 1nbibited 
the incorporation of mevalonate-2-C14 into the DOn-saponifiable 
lipid fraction. As in previous experiments. the arylau.lfonyl-
urea. had no effect on this fraction. 
When the 1soprenols were iaolated from the anaerobic 
incubationa, aaa1n the same results were obtain.d as in .erobic 
incubation.. The data in Table 14 show that tllben plum.thy1-
b1&uanide we pr .. ent. there w.. an 1ncr .... in the 1ncorporatia 
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TABLE 14 
EFl'ECl' OF HYPOGLYCEMIC COMPOUNDS ON THE INCORPORATION OP 
... iEVALONATE .... 2_C14 INTO ISOPRENOL PYROPHOSPHATES IN ANAEROBIC 
INCUBATIONS 
Conditions: the conditions were the same as described in Table 13. 
'l'bi concentration of the hypoglycetd.c ~ wla 4 x 10-3 M. 
















of lMValoaae.e-2-C14 iDto th1. neutral fraction. When tolbutamide 
v.. pr ... t t however. no difference MtweeD tlle control and the 
uperiMntal 1rlcuat101l8 could H 00"".0. 
FrOID tbe reaulta 80 far 4i8eu •• ed 1e. i. 8een that __ 
pheDetb,lb1panid. 1s pr ••• t in the incubatiotM. there 18 a 
cieer.... iD the foraatiOl'l of 84f.\141ene. _ increase J.a the 
foraaac.1on of the i.,reG01 •• an4 1\0 effect oa. the clecarbox,l&tioa 
of MValoaate-l-C14• 'I'b.. ary18"1£oa,lUor .... llowever. bad DO 
efiece. OIl 8itA_ tile foraat;i.oD. of squal... the iaopr-.ola" or 
iaopelltc,l pyropboaptaat.. 'roe theae result., therefore, it i. 
clear the pbeneth)'ll»ipaaide iDbJ.bita the bio.yDth .. 18 of ehol .. -
terol fr_ .... loDate-2-C14 between l8opent_,l pyroplto8pbate aad 
.,ual~ •• while the ary18ul£oa,lur ... 1Dbibit cholesterol b10-
xyDth .. 1a after the forutiOD of squal... l'he hypoth .. 1a that 
the 1Db:1bltion of choluterol bio81'1ltAeaiS by pbaethylb1paa1cle 
18 before the formatioD of 84U81eoe and by the arylaulfonylur .. 
co.pouncia after the fOnlAtlon of a .. 1... ..... therefore. exper1-
MDtaI1y proven. 
The further .lucidat1oD ef the sie.e of 1Dblbit1oa of 
cholutero1 ld.oa)'Dth .. 1a by the h7P0alyc-.1c co.pounda ... done 
with only two C08IpO\mds. tolbut.aa1de. an ary1au.lfODy1urea. and 
19 
ph.eth,lbiguaaide. The other two ar,lsulfonylur ... , cblorpro-
paaide and _tabexaide, were DOt uaed since it would DOt s_ 
likely that they would have a dUferent re.ult frOll that of 
tollNt_ide. this is in ear_at with tbe workers in the hypo-
Ilyc .. ic fleld who found that the only difference between the 
varioua arylsulfonylureas ls the potency 10 reducins blood suaar 
l..,els. 1D atrapancreatic studi .. J no difference, to this date J 
between the ar,lsulfonylurea co.pounds h.s been observed. 
THE SITE or THE .m VIm UHIBITIOIt or CHOLESTEROL BIOStMTHESIS 
BY TOJ.JIOTAKll)E 
When ..valonate-2-C14 is incorporated into chol .. terol 
b, liver tu.G,enates or llver .. ,.. syst_. OIle of the labels 
fre. .."alonate-2-C14 18 found to r .. ide in one of the thr .. 
.. thyl &roups of lanosterol not pr .. ent in the cholest.rol 
.,lecule. When laoaterol 18 decarboxylated t one .,lecule of 
e140 2 is obtdDed for .,er, .,lecule of lanosterol decarboxylated. 
The theoretical ratio of the yield of labeled cholesterol to 
labeled (Xl2 1s .5:1. an4 this value baa been approached by tbe 
actual expert.eDtal value (16) (17). 
SiDee tolbutaaide inhibits chol .. terol biosynthesis 
after the foraetion of .... 1 ••• the c1402 obtained ire-. iDCU-
90 
hat-ions with mevalonate .. 2-c14 was collectecl al1d determi.ned a8 
B&c140,. table 15 abovs that tolbutamide inhibits the decar-
boxylation of lanost.erol approximat.el.)' to the same QQ6l'ee as it 
iPhi.bi.ta the formation of cholesterol. However J this could not be 
the polnt at. whic::h the inhibition take. place. If the decar-
boxylation of lanosterol 18 1nh1b1ted by tolbutamide .U£ J.!. f.t 
~t be expected that there would be an accumulation of lano-
sterol in the mixtures containin& tolbutamide. However J if this 
w.. the case, DO observable inhibition of cholesterol should be 
observed aince both lanosterol and cholesterol are precipitated 
by d1a1tonin. which 16 specific for 3-beta hydroxy steroids. In 
other wrda. aiDce both lauoaterol and clloleaterol are precipi-
tated by dijitooill. the decrease in cholesterol biosynthesis 
'WOUld be counteracted by the accumulation of lanosterol. and no 
difference in the diaitonidea would be observed. This. of cour •• , 
ia DOt true. Almost every table so far preaentad showed that 
~~. waa a deer.... in the di&iton1n precipitable material 
wtaeaevc: tolbut4laid. wu preaent in the mixture. The inhibition 
of cboleacerol could DOt. therefore, take place at the decar-
boxy1at1on of laosterol. It would 8e_. therefore, that the 





EFFECT 01' TOLBU'rAMlDE ON THE PORMATtaf OF CO2 FROM MVA_2_0
14 
Conditions: the conditions were the same as described in Table a 
wIth the excepti_ that 0.76 tJ.C of 0-14 waa used. 1'he COl\C81l-
tration of ~lbu.t_ide was 4 x lo-3M. Aerobic incubations at 37°C 
















by tolbu.t:aIIlidc is at the cycllzation of squalene. The proof of 
this tJ.lgh.t well be provided by the ntudy of the incorporation of 
~ r mevalonate ... 2-C into lanost(:lrol with and without added tolbuta- ~!ill 
tude. 
This, however, is not a simple ta.sk. In normal incu-
bat ions , as soon as lanosterol 18 formed it is metabolized alaoet 
instantaneously. The proof of the site of inhibition by tolbuta .. 
mide could not be done by the use of l:egular incubations sineG 
only traces of lanosterol can be found. Any changes observed ill 
the fonnation of lanosterol would not have any significance. 
The work of Moller and Tehan (l07) showed a way to 
circumvent the difficulti.s that would aris. in the study on th. 
incorporation of mevalonato-2-Cl4 into lanosterol. They have 
found that when mavalonate-2-C14 was incubated under aerobic 
cond1tiOllS with rat liver homogenate. and the proper cofactor., 
substantial amounts of labeled carbon dioxide were formed. 
Addition of arsenite inhibited the formation of labeled carbon 
dioxide without affecting the yield in labeled non-saponifiable 
lipid. Cbromatoaraphy of the non-saponifiable lipid material 
revealed that over 9a.r. of the label was aasociated with the 
sterols J and that very little c14 was present in the squalene 
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fraction. Since the coQveratoa of ..valonate-2-C14 to lano.terol 
wulel DOt &1ve riaa to labeled CO2, "81'''' the formation of 
chol •• terol Mould be accGaIpal\ie4 by the foraatioD of radioactiv. 
earboD d1oxide, it appeared 11kely that tbe labeled product v .. 
laBOstarol. l'h18... coaf1ned .y the fo1low1na ev1cl_ce. Vb_ 
labeled ..... 1 ... prapared by inc"'ti. _v41oaata-2-C14 vith 
rat 11ver ...., .... t. ua4er .... 01»10 COD41tiooa. v.. 1acuhated 
with rat I1ver II1cro.~ _d aolub1e ,roteln., Nth labeled 
aterol ad laMled C02 .. zoe fonaecl. 'lb. addition of ar •• lte 
.. lubed the fOl'll&tlOD of CO2 v1tbout a!fHtiDI the 71e1. of 
aterol. Vb_ the labeled .t .. l, obta1De4 ill the , .... eDea of 
.. aardCa, .a racryaCal11aecl with chol .. tarol, the oqata1a 
ODCa1aed after two recrYltailiut10Ba had no radioactivity. Wba 
the l ... lad aterol "aa recry.tal11aec1 with 1 .... ten1. the radio-
activity r_iaecI vith the cryatala ale_ thr .. recryaealltaa-
tloDa. 
., ,Z'.1I'lcubatioa of th. liver _1M ayle. vlth 
8rlal1ee, tha effact of tellJuc.-1ct. em the 1Deorpor.ciOll of 
.. aloaate-2-C14 iato laDoat .. ol could be 8Cudt.cl. by cD_ 
tluat would be ob.erved uader th ... eoad!t! •• wulel reflect tbe 
effect of tolbutamide OIl 1 .. lt.o1 bi .. ,.dl .. 1a. 
p:z 
The liv.r _,.. .y.t_, capabl. of ')"Ilth .. 1a1aa 
chol •• C.rol aDd men .... , va. fir., preiDcubatecl with 10.3 M 
ar •• it. for ... bour at flOC. After the pr.iDcubat1cm period 
" .. ttmd.Dated, aevaloaat .. 2-C14, .terol eoeDII:r-a. aDd colbu.ta-
.u. (4 II 10.3 It) .......... and the aixtura ... tneubat." .t 
3~C for t:.wo hour.. !b. react1 ........ th_ .toppM aM lb. 1IOft-
• .,..U .... l. ltp'd extr.cted. 'lb. '-beta hydroxy aterolc1a were 
tbeIl precipltated by dl,lcoa1a after .wltl_ of traea __ c. 
of _label_ lao.terol ... chol.atarol. Th. " •• lte 1. Tabl. 16 
.law tbat laBOlt .. l for.atioa fr. MfA_2.e14 1a iDb1bit" by 
toUNt_leI. to tha _ ac_c .. chol .. te'l"Ol ... ia the prev'_ 
exper1aeaca. !b. cabl. __ .lao that CO2 product1oa 1a .lao 
1abu.:1t.s .or. by tolbutaid. aad ar.elt. ChaD by arHD1t. .1 .... 
Siac. .a.lt. 1Db1t.1ta tbe • ......,latloa of 1_-
aterol, lt abewa chat __ tol_taid. :1. alao pru.t, the 
.ffect 1. a.alatl'M, 1 ••• t t01but.-1 •• ad .. e.lta 1ab1blt the 
deearboxylatioa of 188O.t..ol .... tbaa ... ait. dou aloae. The 
decr_. f.D th. r.l .... of CO2 11, co1buc..td. 18 du. of coura. to 
the d1ld.aiahed aval1a'bl11ty of l ... tarol clue to th. 1ah1blCioa 
of the cycl1aatioD of ... 1 •• (deer __ 1_at.rol productloa 




EFFECT OF TOLBUTAMIDE 00 THE FOlt.'\fA'.rION OF LANOSTEROL FROM 
MEVALONATE_2_C14 
Conditiona: same aa in Table 8 except that each flask was gre-
tiiCULatact With 0.001 M araenite and the enzyme syatem at 0 C 
before the od\er additions were made. '1'he enzyme system ccm.tain~ 
23.4 mg of protein. The concp-tratlOD. of tolbutamide was 4 x 10'" 



















epec1f1c 1Dhibitor of the decarboxylation of lano.tero1, tar-
m1nat1Da the blo.ynthetlc pathway of ebola.tercl at lanosterol. 
The proof that the COIIIpOl.1nfI obtained in this type of 
an 1DcubatioD wa_ laDOfItero1 and DOt cho1e.tero1 .aa aecoaapl1abecl 
by one of the _thod. used by Meller aad reb_ (107). Table 17 
.... that lIb_ the .tero1 wa. rec:ry.tall1aed twice with adcled 
chol .. terol, the erystal. obtained had practically _ radio-
activity. Wh.a the labeled .tero1 Val reery.talllHd with 
1anoaterol, al.llllo.t all the radioactivity reaa1.necl with the 
crystal. after two recry.ta111aatlon.. '1'hl., of cour.e, .hou1d 
be GO aurprtae. .1I'Iee the _tbod u.ed for the .tudy of the in-
corporation of ..v.loaace-2-C14 tnto lano.terol wa. that of 
Moller aD4 Teb_. and it ehou1d be expected that the radioactive 
coapound 1 .. lated .hould be lanost .. ol. 
Tolbut.-1de. therefore, al.o iabibit. the fOr.ation of 
lano.terol fr • ..valonate-2-C14• Previoualy. it va •• hown that I, 
.qual.e '1Dth .. ia va. DOt 1Dh1ltlted by tolbut_ide 18 anaerobic 
iacuDat10aa (Table 14). The blo')'Ilthetic pathway, therefore, 
B.l8t be interrupted by tolbutaide at the cycliutioa of 
.qua1.e. Thi. would iacU.cate that if the lncorporatioa of 
aevalooate-2-c14 ... allowed to proceed to cb01 .. t.ol (aerobic 
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TABLE 17 
THE IDENTIPICA1'1ON OF THE STEROL OBTAINED DUR.ING INCUBATIONS 
WITH ARSENITE 
Measurement. of 014 Control Tolbutamide 
Non-saponifiable lipid 
Original activity thought 
to be lanosterol (.a the 
digitonicle 
After two recrystallizations 
with lanosterol 













incubations with the addition of alutachion.), an incr .... in the 
fontation of ... 1 ... should be oNerved. Previoua up ___ ta 
in which squalene waa i.olated were stopped at the formation of 
aqual._ by utilising anaerobie iDeubation •• and a •• uch, no 
dUfereaee betweeD the control. aad tolbut_ide ccmtahd,DI1I1x-
ture. would be expected and were DArY'er obtained. 
The re.ults in Table 18 show that if the Mtabolic 
sequence i. DOt tendnated until ehol .. terol 18 fo~. ther. i. 
a eonc.tn&nt incr .... in the formation of 'qual •• with the 
drop in choleaterol syntb .. 1sed ill bacubatlou eoa.talD1q tol_-
t_1de. Th. deer .... in chole.terol b1e.,.tb.al, _. tol1Nta-
1If.de 1, added to the iftCUltationa can be accouatecl tor by the 
increased produetlon of ... 1.. as .hown in Table 19. 
The exper:1meDtal data 8bowa that tolbue.1de 1Db.f.bit. 
the fOJ.'MtlOD of both ebol.aterol and laao.terol. but iller ..... 
the formation of equalene. Ther. ia no dou'bt, therefora. that 
tolbutamide inhibits Cholasterol bloayntb •• is fro. ... alooat.-
2_cl4 between aqualene and lanoeterol or at the 01e1ia8tion of 
squa1.e. 
THB SITI or THE 1I VIDO DHIBI'lIOll or CHOLESTEROL IIOSYWrHlSIS 
BY PHEDTIYLIlGUAliIDE 







EFFECT OF TOl.JSUTAMIDE ON THE roDiATION OF SQUALENE PR.OM 
MEVALOKATE_2_C14 
Conditions: the conditions were the same as described in Table 8 
WlMi Bie 'DOted. exceptiona. The concentration of tOlbgtamide wea 
2.! x 10-3 M. All i'ncubationa were carried out at 37 C for two 
hours. 



























EFFECf OF TOLBUTAMIDE ON THE INCORPORATION O'F MEVALONATE_2 ... C14 
INTO THE TOTAL NON-SAPONIFIABLE LIPID, SQUALENE, AND alOI.,E ... 
STEROL 
The number of micromol.. of mavaloaate incorporated into the 
different fractions was calculated from the results in Table 18. 





Squalene + Cholesterol 
Control To1but~ide 









auanide decrea.ed the for.ation of .qualen. and incr •••• d the 
formation of the i.oprenol.. Thi •• u" •• ted that th. inhibition 
.a. at th. i.opreno1 .tq. in th. bio.7Dth •• i. of chol •• terol. 
To obtain further support for this .it. of tnbibitioD. incuba-
tiona were .tarted without th. addition of ticro ..... to th • 
• yet... Thi. o.i •• loo .topa th. bio.1Othetic pathway at th. 
C15-18opreo1 pyrophosphate. fameao1 (63). At th. end of th. 
fir.t hour of incubation •• oae reaction. vere stopped by lOB 
aocI the i.o,reool fr.ction _tr.cted and analyzed. To ... of 
the other be •• tiOD.. 0.2 a1 of aicroaa.ea ... acklecl. _il. 
other. ..... l.ft without aicr...... The 1ncubat:l.oa ... e th_ 
allowed to proceed for another hour. At the end of the .ecood 
hour the reactiooa were .topped and the i.opreaol fraction 
anal)'11ec1. 
The data in Table 20 .bows that when the ticro .... 
were o.itted fl."Oll the iIlcubatloa IDixtur ... the fo .... tioo of the 
iaopreaol. fro. .. v.lonate-2-C14 in both control. and incubations 
CODtainiai p"-t.thylbipalde were th. s_. Tbi •• as true 
.ether tlle 1Rcubatlon period va. ODe or two bour.. Th. ineor-
,oratlOD of .... lonat.-2-C14 1nto the isopranol fr.ction after 
two hour. was aucb b1&her than .ft.r on. hour. but DeYerthel ... 
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TABLE 20 
EFFEC'1' OF PHENETHYLBlGUANIDE ON THE FORMATION OF ISOPRENOL-
PYROPHOSPHATES FROM MEVALONATE_2_C14 
Conditiona: Each flaak contained 1.0 m1 of dialyzed soluble 
ens".s (1:8.0 mg of protein); NADB (2 i£IIOles); NADPH (1 .... le); 
A'tP (30 J.LIDOlea); reduce.d glutathione (30 lJlDOlea); MgC12 (16 
iJlUOlea); MnSO~ (4 ..,molea); and meva~c acid (0.5 ..,mole, 0.25 
~C of 0-14). Aerobic incubations at 37 c. 
Time of laoprcmol Pyrophosphate. 



















the same for both controls and phenethylb1guanide containing 
incubations. 
If microsames were added at the end of the f1r.t hour, 
the isoprenol pyrophosphates in the controls were further 
metabolized to cholesterol as evidenced by the deerease in radio-
activity after two hours when micros01D8s were present (Table 20) 
and tbe appearance of synthesized cholesterol (Table 21). In-
cubation. containing pbenethylblsuanlde, however, had the __ 
amount of radioactivity as.ociated with the isoprenols whether 
the microlomes ware added or DOt. Th. cholesterol formed in the 
phenethylbiauanlde containing incubation. when the mierolOMs 
were added va. much 1... than when phenethylbiguanUe was abIent 
frca the incubation _dium (Table 21). l1te enzymes contained 
in the microaomu that transform the iaoprenol. into .qualene 
and subsequently into cholesterol were unable to metabolize the 
isoprenol. when pbenethy1b1auanlde was present. This indicates 
that the biosynthe.is of cholesterol from mevaloaate-2-C14 i. 
interrupted by pheaethylblsuanide at some isoprenol. 
In order to find out Whicb compound or compounds con-
tained thi. b1gb radioactivity when pbenethylbiguanlde is 
pre.ent, the isoprenoll had to be .eparated and identified. Of 
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TABLE 21 
EFFECT OF PHENETHYLBIGU.ANIDE (II THE BIOSYNTHESIS OF 
CHOLEST&ROL FROM MEVALONATE-2_a14 IN THE PRESENCE AND ABSENCE OF 
MlCROSC»ms 






after 1 hr. Incu-
bations contil'lUed 
















the a\~ methods commonly used for the identification of these 
compounds, gas-liquid chromatography and paper chromatography, 
the latter was the more feasible, although more involved. 
Dimethylallyl alcohol, geraniol, farnesol, and nerolidol cannot 
be separated by paper chromatography as such. The separation of 
these compounds can only be done after a suitable derivative of 
the alcohol function is made. The derivative of choice was the 
3,' .. d:1nitrobenzoate. After many methods were tried, the method 
of Cheronis and Entrilcin (33) was adopted and 1. liven in the 
chapter on materials and methods. Thi. method was ehoaen since 
it gives good derivattvu of small quantities of not only primary 
and secondary, but also of tertiary alcohols. This i. important 
since nerolidol, a tertiary alcohol appears in the fraetion that 
was analyzed. 
Figure 17 shows the radiochromatogr_ obtained from 
the reverse ph ... chromatography of the i8oprenol-3,5-dinitro-
benuat... There was a larae accumulation of a compound haviq 
an Itf value of 0.32 in iDcubation. cont.iains phenethylbisuaaicle. 
This eorreaponda to farn •• ol and nerolidol-3,'-dinitrobenaoat •• 
as shown by the movement of authentic sample. of the derivative •• 







" \ ~~ , 
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RADIOCH&OMA.TOORAMS or THE lSOPIt.l!!H0L-3,5-DlNITROBENZOATES 
Ra".rae phas. chroIutography an Yhatman No.1 paper imp~ted 
with 10'1. medlum mineral 011. ne".lopmg solvent - 7S~ acettc acto. 
To~:5r.~reproduction of a radiochromatograph of isopranol-
! til btmsoatea obtaifted from f:ncubatiOll mixtures - Broken 
line - CONTROL; solid line - INCUBATIONS CONTAINING PHENETHYL-
IIGt1ANlDE. Pull aoale deflectlO1l • 100 .pm. Bottoat !ae : repro-duction of the separation obtained from 3.5-arftltro~nBoyl 
derivatives of authentic aamples of the iaoprenols. The origin i. 
at the rigbt; the solvent front at the left. 
107 
a&ain waS laq~er in incubatiOtlS that contained phenethylbliU&Dide 
as compared to the ones that did not. 'rhis is thought to be 
free nuolidol t since authentic samples of free nerolidol stayed 
at the origin in the system that was used. Also, if the re-
fluxing during the making of the derivatives was increased from 
one to two hours, the radioactive peak at the origin disappeared 
and a concominant rise in radioactivity with an Rf value of 0.32 
was observed. 
In order to separate the farneaol and nerolidol-3,S-
dinitrobenzoates, the solvent front waa allowed to run off the 
paper. By this method the two CLS-lsopreaol-3.S-dinitrobenzoat .. 
were reasonably separated. The farnesol-3,S-dinitrobenzoate 
came first and resolved into a sharp peak, followed by a larae 
drawn out band of radioactivity corre.pondina to nerolidol-3,S-
d1n1trobenzoate. The results in !'isure 18 show that the radio-
cbromatoaras of the isopreno1 derivativ.. frOli incubations 
contain1D& phenethylbisuanide had an increased formation of 
famesol and nero11dol .s eoapared to incubations in which 
pbenethylblpanide was not present. In order to obtain the 
amount of radioactivity present in theae compounds. plan1metry 
vas used to obtain the areas under the peaks obtained from the 
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FIGURE 18 
THE SEPARATION OF FARNESYL AND NEROLIDYL-3.5-DINITROBENZOATES 
Reverse phase chromatography on Whatman No.1 paper impregnated 
with 10~ medium mineral oil. Developing 101vent - 75% acetic acid. 
TO~ ~ra~h: reproduction of a radiochromatogram of isoprenol-
3, - in trobenzoates obtained from incubation mixtures - Broken 
line - CONTROL; solid line - INCUBATIONS CONTAINING PHENETHYL-
BIGUANIDE. Full scale deflection = 250 cpm. Bottom ~raph:repro­
duction of the separation obtained from 3,5-dinitro enzoyl 
derivatives of authentic samples of the isoprenols. The origin is 
at the right; the solvent front was run off the paper in order 







reverse phase ~hroms.togrJ3.?hy of the isopre:t101-3,S-dinitrobenzo-
a.tes. Table 22 shows essentia.lly the same picture as discussed 
above, except that the results are tabulated In terms of the 
amount of radioactivity (cpm) present in the different isoprenola. 
Allyl pyrophosphate.. in cc:mllon with other substances 
in which a potentially anionic group is in th. alpha-position to 
a double bond. are electrophl1ic compounds and can be expected 
to lose the pyrophosphate ion rather readily. lbe electron 
deficient species resulting from the elt.1nation of the pyro-
phosphate ion, may be partially stahili.ed by resonance between 
two equivalent forma <as discussed in Chapter I). In the pres-
ence of water, the two forms may yield. by the addition of a 
hydroxyl ion, either a primary or tertiary alcohol. This is the 
_chanin of allylie rearrangement, and vas found by Goodman and 
Popjak (116) and Lynen .IS. .t!.. (93) to be responsible for the 
conversion of a large part of farn.sol pyrophosphate to nerolldol 
during acid hydrolysis of the isoprenol pyrophosphate •• 
lbe nerolidol obtained 1n "lsure. 17 and 18, and in 
Table 22. therefore, actually comes from the rearrangement of 
fam.sol pyrophosphate durin, the iaolation procedure. The 









QUAN~rITATION OF THE RADIOCHROMATOORA1'-1S OF ISOPRENOL-3,5-
DINITROBENZOATES 















:3 t.5-d1nitroben~~oates is actually an indication of the radio-
activity originally present in famesol pyrophosphate. Phene-
thy lb lauani de , then, increases the formation of farneBol pyro-
phosphate. From data previously discussed, it was seen that 
pbeneehylbtsuanide alao deerea.es the incorporation of 
mevalonate-2-C14 tnto squalene. The site of inhibition of 
eholeaterol biosynthesis by pbenethylbiguanide 1a J therefore J 
between famesol pyrophosphate &lDd squalene J stopp1n& the bio-




The action of the hypoalycemic compounds, tolbut .. ide, 
chlorprop..u.de, metabexamide. and pbenethylblauan1de, on the 
blosynthesl. of choleaterol ba. been tnve.tl.ated Ja vitro with 
aevalonate-I-Cl4 uatna a rat liver enzyme sy.t... The r .. ult • 
• how that the lncorporation of aevalonate-I-C14 tnto ebole.terol 
18 inhibited by all compounda atudied. The .. faal inhibition 
occur. wben the concentration of hypoalyc..tc co.pound ia 
4 x 10.3 M. 
The -.nner in Which the.e compound. inhibit chole.terol 
bioaJllth .. i8, h01M'ler. i. qulte different. Ph.ethylbipaaide 
decr..... the formatioa of the noo-saponifiable lipid. aDd 
choleaterol by approximately the .... ..ount fro. ..valonate-l-
el4• Thi. would ~ly that pbenethylbiauanide 1nbibita the 
bio.ynth •• ia of cholesterol before tbe for.ation of the choles-
terol iftter.ediate found in the DOD-.aponifiable lipid fraction. 
'l'hls i •• ubstatlated by the lDhiltitlon of .qualene for.atlon 
froID ..valonate· l-e14 • 'urtber.re. there la an accuallatloa of 
the isopreoola. pre-•• alene cholesterol tnterMCIiate.. Rever.e 
pha.e cbro.atoarapby of the 3.5-diftitrobeaaoate derivativ .. of 
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the .lcohol. showed Chat the accumul.tion of r.dioactivity ••• in 
the fam .. ol deriv.tive. It follow that pben.thylhiauanlde 
interrupt. the biosynthesi. of cholesterol at the level of the 
Cu -isoprenol, farn •• ol pyropho.phate. 
the aryl.ulfonylur •••• tolbutamide. chlorpropamide, and 
•• tabex .. id., howev.r, .re different aa rel_rds their effect on 
the bio.yntheai. of chol •• terol. Th.y do not inhibit the incor-
por.tion of mev.lon.te-2-Cl4 into the non-•• ponifiable lipid and 
chol •• t.rol by the .... meanitud.. St.rtin& with mev.lonat.-2-
C14• there is .bIo.t no difference h.tween the non-•• ponifiabl. 
lipid for.ed when the .ryl.ulfonylur.. compound. .r. pr •• ent or 
absent from the incub.tion mixtur., and yet chol •• t.rol b10.10-
th •• i. i. inhibited. When th. i.oprenol •• nd .qu.len. are 
iaolated, th.re aaain i. no diff.renc.. When, howev.r, lano.terol 
was i.ol.ted, th.re .... d.cr •••• in its for.ation corr •• pondinl 
to the deer .... obt.ined in chol •• t.rol .ynth .. is.d frOil 
.... lonat.-2-Cl4• And fin.lly, when squ.len .... i.ol.ted aft.r 
.erobic incub.tions, th.r .... an incr •••• in it. fonaation when 
tolbut .. id .... pr •• ent in the incub.tion aiatur... Th. incr •••• 
in .qualen. formation from .. v.lon.t.-2-Cl4 could b. expl.ined by 
the d.cr.... in the biosynth •• i. of chole.terol in the .... in-
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cubations. It follow., therefor., that tolbutamide inhibits 
cholesterol biosynthe.is from mevalonate-2-C14 betv.en squalene 
aDd lanosterol, or more precis.ly, at the eyelia.tioa of squalene. 
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APPE'NDL< 
lrUar.tion of thea Buff tar .oluSion: 
'The buffer solution uaed in all incubations waa prepared 
as follow: 13.969 I of K2HP04 (AR, HalliDckrodt CheaDlcel Co.); 
2.695 I of iCH2P04 (Ar, Mallinckrodt CIt_ical Co.); 0.978 i of 
MaCl2.61120 (AR. Mallinckrodt Chemical Co.); and 3.664 I of 
aicotinamide (lot 133'1, Nutritional Biochemicals), was .,d. up 
to em. liter ncb doubly» ews distlllecl ".ter. Tb.. final 
molarity of the solution was 0.1 with re.pect to phosphate, 0.03 
Ie w:ltb respect to nicotinamide, and 0.0048 M with respect to 
Mael2• The Pd, .s .... ur.d by a Beckman pH meter, was 7.4. 
Pltt!!'lDiytlon of hotey: 
lbe prot.in contained in the enzyme .ystem was measured by 
the biuret r.eaction (64). The biuret reaaent was prepared as 
follows: 0.640 I of anhydrous CuS04.SHzO (AR, Mallinckrodt 
Cbeaical Co.) and 6.0 a of DaC.Ht.06.4H20 (AR. Mallinckrodt 
atem.cal co.) dissolved in about 500 .1 of water. 'ro this .,s 
added 300 ml of lO~ NaOH and the solution was diluted to one 
liter. When this solution is added to prot.in solutions" • 
viol.t color r.sults. 
1.34 
4 ml of the color reagent was added to the enzyme syst_ 
or atandat-cl. The final volume of S ml was made up with doubly 
distilled water. After mixing, the color was allowed to develop 
for 1.5 minutes slld them determined in a Klett colorimeter uaina 
a '54 filter. Crystalline albumin from bovine serum (lot Iw 
69312, Armour Pharmaceutical Co., Kankakee. Illinois) waS used to 
prepare the standard curve illuatrated in Figure 19. 3tandardG 
were alway. run atmultaneously with the unknown enzyme .yst .... 
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PROTEIN (MG) 
FIGURE 19 
STANDARD CURVE FOR THE BImtET :?ROTEIN DETER.l>1INATION 
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TABIB 23 
STANDARD ClJRVE FOR THE BIURET PROTEIN DftERMIMA'l'tON 











NO. 54 filter was used for the readings. 
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TABLE 24 
THE SOURCE OF CHEMICALS USEn IN '!'HE INVESTIGATION NO'!' 
DESCRIBED El.sEWHERE 
1). Aluaina, activated. 80-200 meatt. eu-atographic absorption: 
Merck and 00., Rahway, H.J. 
2). ADmcmium Sulfate, AR: Mallinckrodt: Chem.ical Co., New York. 
3). Acetic acid, sodium salt, AR, lot #J'NA. Mallinckrodt 
Chemical Co., New York. 
4). Chole.terol, lot #5177'1 Mathea •• COleman and Bell 00., 
East: Rutbeford, N.3. 
5). Digitonin, ARt lot # D 3046. Mann Research Laboratories, 
Inc., Hew York. 
6). 3.S-Dhdtrobeazoyl Ohloric1e. IB.p. 68-69°: Matheson. Coleman 
and Bell, East Rutheford, N.J. 
7). Pa.m.esol, lot #8, Chemicals p~t Laboratories, Inc., 
College point, N.Y. 
8). Geraniol, lot #35152 L: K and K Laboratories, Inc., Jamaica, 
N.Y. 
9). Lanosterol, 0 grade, lot #106938: california Corporation 
for Biochemical Research, Los Angeles, calif. 
10). Neroltdol. lot #35884: K and K Laboratories, Inc., ..Jamaica, 
N.Y. 
11). Sodium Arsenite, ARt lot #28108, J.T. Baker Chemical Co., 
Phillipsburg, N.J. 
12). Squalene, lot /I A 5664: Mann Research Laboratories, Inc., 
New York, N.Y. 
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